Workday (WDAY) 10-Q 4 Dec 24 2025 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares shares in Millions	9 Months Ended
	Oct. 31, 2024	Nov. 29, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2024
Document Transition Report	false
Entity File Number	001-35680
Entity Registrant Name	WORKDAY, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2480422
Entity Address, Address Line One	6110 Stoneridge Mall Road
Entity Address, City or Town	Pleasanton
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94588
City Area Code	925
Local Phone Number	951-9000
Title of 12(b) Security	Class A Common Stock, par value $0.001
Trading Symbol	WDAY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001327811
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		214
Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		52

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Current assets:
Cash and cash equivalents	$ 1,311	$ 2,012
Marketable securities	5,846	5,801
Trade and other receivables, net	1,404	1,639
Deferred costs	244	232
Prepaid expenses and other current assets	273	255
Total current assets	9,078	9,939
Property and equipment, net	1,263	1,234
Operating lease right-of-use assets	335	289
Deferred costs, noncurrent	490	509
Acquisition-related intangible assets, net	383	233
Deferred tax assets	1,031	1,065
Goodwill	3,479	2,846
Other assets	365	337
Total assets	16,424	16,452
Current liabilities:
Accounts payable	74	78
Accrued expenses and other current liabilities	323	287
Accrued compensation	476	544
Unearned revenue	3,447	4,057
Operating lease liabilities	102	89
Total current liabilities	4,422	5,055
Debt, noncurrent	2,983	2,980
Unearned revenue, noncurrent	64	70
Operating lease liabilities, noncurrent	278	227
Other liabilities	53	38
Total liabilities	7,800	8,370
Stockholders’ equity:
Common stock	0	0
Additional paid-in capital	11,115	10,400
Treasury stock	(1,208)	(608)
Accumulated other comprehensive income (loss)	16	21
Accumulated deficit	(1,299)	(1,731)
Total stockholders’ equity	8,624	8,082
Total liabilities and stockholders’ equity	$ 16,424	$ 16,452

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Millions		3 Months Ended		9 Months Ended
		Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenues:
Revenues		$ 2,160	$ 1,866	$ 6,235	$ 5,337
Costs and expenses:
Product development	[1]	647	619	1,952	1,829
Sales and marketing	[1]	620	538	1,804	1,581
General and administrative	[1]	198	176	609	512
Total costs and expenses		1,995	1,778	5,895	5,233
Operating income (loss)		165	88	340	104
Other income (expense), net		62	41	178	114
Income (loss) before provision for (benefit from) income taxes		227	129	518	218
Provision for (benefit from) income taxes		34	15	86	25
Net income (loss)		$ 193	$ 114	$ 432	$ 193
Net income (loss) per share, basic (in dollars per share)		$ 0.73	$ 0.43	$ 1.63	$ 0.74
Net income (loss) per share, diluted (in dollars per share)		$ 0.72	$ 0.43	$ 1.61	$ 0.73
Weighted-average shares used to compute net income (loss) per share, basic (in shares)		265,411	262,153	265,062	260,747
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)		268,549	266,377	268,936	264,087
Subscription services
Revenues:
Revenues		$ 1,959	$ 1,691	$ 5,678	$ 4,843
Costs and expenses:
Total costs and expenses	[1]	329	264	924	759
Professional services
Revenues:
Revenues		201	175	557	494
Costs and expenses:
Total costs and expenses	[1]	$ 201	$ 181	$ 606	$ 552
[1] (1) Costs and expenses include share-based compensation expenses as follows: Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Costs of subscription services $ 35 $ 30 $ 108 $ 90 Costs of professional services 28 29 86 87 Product development 162 162 498 494 Sales and marketing 78 65 226 212 General and administrative 65 63 204 188 Total share-based compensation expenses $ 368 $ 349 $ 1,122 $ 1,071

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Share-based compensation expenses	$ 368	$ 349	$ 1,122	$ 1,071
Costs of subscription services
Share-based compensation expenses	35	30	108	90
Costs of professional services
Share-based compensation expenses	28	29	86	87
Product development
Share-based compensation expenses	162	162	498	494
Sales and marketing
Share-based compensation expenses	78	65	226	212
General and administrative
Share-based compensation expenses	$ 65	$ 63	$ 204	$ 188

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 193	$ 114	$ 432	$ 193
Other comprehensive income (loss), net of tax:
Net change in foreign currency translation adjustment	1	(4)	(2)	(3)
Net change in unrealized gains (losses) on available-for-sale debt securities, net of tax provision (benefit) of $2, $0, $2, and $0, respectively	5	(4)	7	(16)
Net change in unrealized gains (losses) on cash flow hedges, net of tax provision (benefit) of $(1), $2, $0, and $4, respectively	(9)	48	(10)	(1)
Other comprehensive income (loss), net of tax	(3)	40	(5)	(20)
Comprehensive income (loss)	$ 190	$ 154	$ 427	$ 173

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Statement of Comprehensive Income [Abstract]
Unrealized gain (losses) on available-for-sale debt securities, tax provision (benefit)	$ 2	$ 0	$ 2	$ 0
Change in unrealized gain (losses) on cash flow hedges, tax provision	$ (1)	$ 2	$ 0	$ 4

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common stock:	Additional paid-in capital:	Treasury stock:	Accumulated other comprehensive income (loss):	Accumulated deficit:
Balance, beginning (in shares) at Jan. 31, 2023		257,991
Balance, beginning at Jan. 31, 2023		$ 0	$ 8,829	$ (185)	$ 53	$ (3,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans (in shares)		5,926
Issuance of common stock under employee equity plans		$ 0	95
Issuance of common stock in business combination (in shares)		0
Shares withheld related to net share settlement of equity awards (in shares)		(61)
Shares withheld related to net share settlement of equity awards		$ 0	(13)
Share-based compensation			1,071
Common stock repurchased (in shares)		(1,312)
Common stock repurchases under share repurchase programs		$ (286)		(286)
Other comprehensive income (loss)	$ (20)				(20)
Net income (loss)	193					193
Balance, ending (in shares) at Oct. 31, 2023		262,544
Balance, ending at Oct. 31, 2023	6,625	$ 0	9,982	(471)	33	(2,919)
Balance, beginning (in shares) at Jul. 31, 2023		261,858
Balance, beginning at Jul. 31, 2023		$ 0	9,638	(324)	(7)	(3,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans (in shares)		1,383
Issuance of common stock under employee equity plans		$ 0	0
Issuance of common stock in business combination (in shares)		0
Shares withheld related to net share settlement of equity awards (in shares)		(20)
Shares withheld related to net share settlement of equity awards		$ 0	(5)
Share-based compensation			349
Common stock repurchased (in shares)		(677)
Common stock repurchases under share repurchase programs		$ (147)		(147)
Other comprehensive income (loss)	40				40
Net income (loss)	114					114
Balance, ending (in shares) at Oct. 31, 2023		262,544
Balance, ending at Oct. 31, 2023	6,625	$ 0	9,982	(471)	33	(2,919)
Balance, beginning (in shares) at Jan. 31, 2024		263,862
Balance, beginning at Jan. 31, 2024	8,082	$ 0	10,400	(608)	21	(1,731)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans (in shares)		6,179
Issuance of common stock under employee equity plans		$ 0	106
Issuance of common stock in business combination (in shares)		24
Shares withheld related to net share settlement of equity awards (in shares)		(2,058)
Shares withheld related to net share settlement of equity awards		$ 0	(518)
Share-based compensation			1,127
Common stock repurchased (in shares)		(2,538)
Common stock repurchases under share repurchase programs		$ (600)		(600)
Other comprehensive income (loss)	(5)				(5)
Net income (loss)	432					432
Balance, ending (in shares) at Oct. 31, 2024		265,469
Balance, ending at Oct. 31, 2024	8,624	$ 0	11,115	(1,208)	16	(1,299)
Balance, beginning (in shares) at Jul. 31, 2024		265,260
Balance, beginning at Jul. 31, 2024		$ 0	10,869	(1,051)	19	(1,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans (in shares)		1,340
Issuance of common stock under employee equity plans		$ 0	0
Issuance of common stock in business combination (in shares)		24
Shares withheld related to net share settlement of equity awards (in shares)		(506)
Shares withheld related to net share settlement of equity awards		$ 0	(123)
Share-based compensation			369
Common stock repurchased (in shares)		(649)
Common stock repurchases under share repurchase programs		$ (157)		(157)
Other comprehensive income (loss)	(3)				(3)
Net income (loss)	193					193
Balance, ending (in shares) at Oct. 31, 2024		265,469
Balance, ending at Oct. 31, 2024	$ 8,624	$ 0	$ 11,115	$ (1,208)	$ 16	$ (1,299)

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 193	$ 114	$ 432	$ 193
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	81	69	235	210
Share-based compensation expenses	368	349	1,122	1,071
Amortization of deferred costs	64	54	185	155
Non-cash lease expense	26	24	77	73
(Gains) losses on investments	(4)	9	6	17
Accretion of discounts on marketable debt securities, net	(28)	(39)	(90)	(111)
Deferred income taxes	5	3	38	5
Other	(8)	(13)	4	(28)
Changes in operating assets and liabilities, net of business combinations:
Trade and other receivables, net	(114)	38	238	328
Deferred costs	(73)	(79)	(178)	(182)
Prepaid expenses and other assets	33	72	57	78
Accounts payable	(15)	(7)	(3)	(62)
Accrued expenses and other liabilities	(12)	(32)	(136)	(219)
Unearned revenue	(110)	(111)	(638)	(375)
Net cash provided by (used in) operating activities	406	451	1,349	1,153
Cash flows from investing activities:
Purchases of marketable securities	(992)	(1,273)	(3,134)	(4,746)
Maturities of marketable securities	848	1,125	2,980	3,596
Sales of marketable securities	48	46	115	93
Capital expenditures	(47)	(60)	(183)	(183)
Business combinations, net of cash acquired	(302)	(9)	(824)	(9)
Purchase of other intangible assets	(2)	(1)	(3)	(10)
Purchases of non-marketable equity and other investments	(3)	0	(10)	(11)
Sales and maturities of non-marketable equity and other investments	0	0	5	0
Net cash provided by (used in) investing activities	(450)	(172)	(1,054)	(1,270)
Cash flows from financing activities:
Repurchases of common stock	(158)	(145)	(597)	(283)
Proceeds from issuance of common stock from employee equity plans	0	0	106	95
Taxes paid related to net share settlement of equity awards	(124)	(5)	(505)	(13)
Net cash provided by (used in) financing activities	(282)	(150)	(996)	(201)
Effect of exchange rate changes	0	(1)	0	(1)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(326)	128	(701)	(319)
Cash, cash equivalents, and restricted cash at the beginning of period	1,649	1,448	2,024	1,895
Cash, cash equivalents, and restricted cash at the end of period	1,323	1,576	1,323	1,576
Supplemental cash flow data:
Cash paid for interest	55	55	110	110
Cash paid for income taxes, net of refunds	13	3	48	35
Non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	66	18	66	18
Accrued taxes related to net share settlement of equity awards	13	0	13	0
Reconciliation of cash, cash equivalents, and restricted cash as shown in the Condensed Consolidated Statements of Cash Flows:
Cash and cash equivalents	1,311	1,564	1,311	1,564
Restricted cash included in Prepaid expenses and other current assets	12	12	12	12
Total cash, cash equivalents, and restricted cash	$ 1,323	$ 1,576	$ 1,323	$ 1,576

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Description of the Business Workday is a leading provider of cloud-based applications for financial management, human capital management (“HCM”), planning, spend management, and analytics. With Workday, our customers have a unified platform with artificial intelligence (“AI”) built into its core that helps them manage their most important assets – their people and money. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated financial statements include the results of Workday, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of our management, the information contained herein reflects all adjustments necessary for a fair presentation of Workday’s financial position, results of operations, stockholders’ equity, and cash flows. All such adjustments are of a normal, recurring nature. The results of operations for the three and nine months ended October 31, 2024, shown in this report are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2025. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024, filed with the SEC on March 8, 2024. Certain prior period amounts reported in our unaudited condensed consolidated financial statements and notes thereto have been reclassified to conform to current period presentation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates, judgments, and assumptions include, but are not limited to, the identification of distinct performance obligations for revenue recognition, the determination of the period of benefit for deferred commissions, the realizability of deferred tax assets, the measurement of uncertain tax positions, the fair value and useful lives of assets acquired and liabilities assumed through business combinations, and the valuation of non-marketable equity investments. Actual results could differ from those estimates, judgments, and assumptions, and such differences could be material to our condensed consolidated financial statements. Segment Information We operate in one operating segment, cloud applications. Operating segments are defined as components of an enterprise where separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assessing performance. Our CODM, the Chief Executive Officer, allocates resources and assesses performance based upon discrete financial information at the consolidated level.

Significant Accounting Policies

Significant Accounting Policies and Accounting Standards	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Significant Accounting Policies and Accounting Standards	Significant Accounting Policies and Accounting Standards Significant Accounting Policies Concentrations of Risk and Significant Customers Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities, derivative instruments, and trade and other receivables. Our deposits exceed federally insured limits. No customer individually accounted for more than 10% of trade and other receivables, net as of October 31, 2024, or January 31, 2024. No customer individually accounted for more than 10% of total revenues during the three and nine months ended October 31, 2024, or 2023. Other than the United States, no country individually accounted for more than 10% of total revenues during the three and nine months ended October 31, 2024, or 2023. In order to reduce the risk of disruption of our cloud applications, we have established data centers in various geographic regions. We serve our customers and users from data center facilities operated by third parties, located in North America and Europe. We have internal procedures to restore services in the event of disruption at one of our data center facilities. Even with these procedures for disaster recovery in place, our cloud applications could be significantly interrupted during the implementation of the procedures to restore services. In addition, we rely upon third-party hosted infrastructure partners, including Amazon Web Services (“AWS”) and Google LLC, to serve customers globally and operate certain aspects of our services. Given this, any disruption of or interference at our hosted infrastructure partners may impact our operations and our business could be adversely impacted. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The standard requires retrospective application to all prior periods presented in the financial statements. We are currently evaluating the impacts of the new standard. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard allows for adoption on a prospective basis, with a retrospective option. We do not intend to early adopt, and are currently evaluating the impacts of the new standard. In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires the disclosure of additional information about specific expense categories in the notes to the financial statements. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The standard allows for adoption on a prospective or retrospective basis. We are currently evaluating the impacts of the new standard.

Investments

Investments	9 Months Ended
	Oct. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Debt Securities As of October 31, 2024, debt securities consisted of the following (in millions): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 1,660 $ 5 $ (1) $ 1,664 U.S. agency obligations 694 2 0 696 Corporate bonds 3,058 12 (2) 3,068 Commercial paper 566 0 0 566 Total debt securities $ 5,978 $ 19 $ (3) $ 5,994 Included in Cash and cash equivalents $ 148 $ 0 $ 0 $ 148 Included in Marketable securities $ 5,830 $ 19 $ (3) $ 5,846 As of January 31, 2024, debt securities consisted of the following (in millions): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 2,072 $ 4 $ (2) $ 2,074 U.S. agency obligations 753 2 (1) 754 Corporate bonds 2,496 9 (5) 2,500 Commercial paper 1,232 0 0 1,232 Total debt securities $ 6,553 $ 15 $ (8) $ 6,560 Included in Cash and cash equivalents $ 759 $ 0 $ 0 $ 759 Included in Marketable securities $ 5,794 $ 15 $ (8) $ 5,801 The fair values of debt securities, by remaining contractual maturity, were as follows (in millions): October 31, 2024 Due within 1 year $ 2,983 Due in 1 year through 5 years 3,011 Total debt securities $ 5,994 We classify our debt securities as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. We consider all debt securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classify these securities as current assets on the Condensed Consolidated Balance Sheets. Debt securities included in Marketable securities on the Condensed Consolidated Balance Sheets consist of securities with original maturities at the time of purchase greater than three months, and the remaining securities are included in Cash and cash equivalents. Interest receivable of $48 million and $35 million is included in Prepaid expenses and other current assets on the Condensed Consolidated Balance Sheets as of October 31, 2024, and January 31, 2024, respectively. The unrealized losses on our debt securities primarily resulted from changes in market interest rates. We do not intend to sell these debt securities and it is not more likely than not that we will be required to sell the debt securities before recovery of their amortized cost bases, which may be at maturity. We did not recognize any credit-related losses on our debt securities during the periods presented. The following tables summarize the aggregate fair value and gross unrealized losses for all debt securities in an unrealized loss position, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions): As of October 31, 2024 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 266 $ (1) $ 120 $ 0 $ 386 $ (1) U.S. agency obligations 142 0 15 0 157 0 Corporate bonds 640 (2) 184 0 824 (2) Total $ 1,048 $ (3) $ 319 $ 0 $ 1,367 $ (3) As of January 31, 2024 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 921 $ (2) $ 78 $ (1) $ 999 $ (3) U.S. agency obligations 234 0 100 (1) 334 (1) Corporate bonds 921 (3) 171 (1) 1,092 (4) Commercial paper 5 0 0 0 5 0 Total $ 2,081 $ (5) $ 349 $ (3) $ 2,430 $ (8) We sold $48 million and $24 million of debt securities during the three months ended October 31, 2024, and 2023, respectively. We sold $115 million and $42 million of debt securities during the nine months ended October 31, 2024, and 2023, respectively. The realized gains and losses from the sales were immaterial. Equity Investments Equity investments consisted of the following (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Money market funds Cash and cash equivalents $ 849 $ 1,017 Non-marketable equity investments measured using the measurement alternative Other assets 242 248 Total equity investments $ 1,091 $ 1,265 Total realized and unrealized gains and losses associated with our equity investments were as follows (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Net realized gains (losses) recognized on equity investments sold (1) $ 0 $ (1) $ (3) $ 2 Net unrealized gains (losses) recognized on equity investments held as of the end of the period 3 (13) (4) (24) Total net gains (losses) recognized in Other income (expense), net $ 3 $ (14) $ (7) $ (22) (1) Reflects the difference between the sale proceeds and the carrying value of the equity investments at the beginning of the period. Non-Marketable Equity Investments Measured Using the Measurement Alternative Non-marketable equity investments measured using the measurement alternative include investments in privately held companies without readily determinable fair values in which we do not own a controlling interest or exercise significant influence. These investments are recorded at cost and are adjusted for observable transactions for same or similar securities of the same issuer or impairment events. The carrying values for our non-marketable equity investments are summarized below (in millions): October 31, 2024 January 31, 2024 Total initial cost $ 210 $ 213 Cumulative net unrealized gains (losses) 32 35 Carrying value $ 242 $ 248 During the three months ended October 31, 2024, we recorded upward adjustments of $5 million to the carrying value of non-marketable equity investments and impairment losses of $2 million. During the three months ended October 31, 2023, we recorded impairment losses of $9 million. During the nine months ended October 31, 2024, we recorded losses related to impairments and exits of $13 million and upward adjustments of $6 million to the carrying value of non-marketable equity investments. During the nine months ended October 31, 2023, we recorded impairment losses of $22 million. Marketable Equity Investments We may hold marketable equity investments with readily determinable fair values over which we do not own a controlling interest or exercise significant influence. As of October 31, 2024, and January 31, 2024, we did not hold any such investments.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We use a fair value hierarchy that requires that we maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: Level 1 — Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 — Other inputs that are directly or indirectly observable in the marketplace. Level 3 — Unobservable inputs that are supported by little or no market activity. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of October 31, 2024 (in millions): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 1,664 $ 0 $ 0 $ 1,664 U.S. agency obligations 0 696 0 696 Corporate bonds 0 3,068 0 3,068 Commercial paper 0 566 0 566 Money market funds 849 0 0 849 Foreign currency derivative assets 0 46 0 46 Total assets $ 2,513 $ 4,376 $ 0 $ 6,889 Foreign currency derivative liabilities $ 0 $ 25 $ 0 $ 25 Total liabilities $ 0 $ 25 $ 0 $ 25 The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of January 31, 2024 (in millions): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 2,074 $ 0 $ 0 $ 2,074 U.S. agency obligations 0 754 0 754 Corporate bonds 0 2,500 0 2,500 Commercial paper 0 1,232 0 1,232 Money market funds 1,017 0 0 1,017 Foreign currency derivative assets 0 46 0 46 Total assets $ 3,091 $ 4,532 $ 0 $ 7,623 Foreign currency derivative liabilities $ 0 $ 27 $ 0 $ 27 Total liabilities $ 0 $ 27 $ 0 $ 27 Non-Marketable Equity Investments Measured at Fair Value on a Non-Recurring Basis Non-marketable equity investments that have been remeasured due to an observable event or impairment are classified within Level 3 in the fair value hierarchy because we estimate the value based on valuation methods which may include a combination of the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the investments we hold. For further information, see Note 3, Investments . Fair Value Measurements of Other Financial Instruments We carry our debt at face value less unamortized debt discount and issuance costs on our Condensed Consolidated Balance Sheets and present the fair value for disclosure purposes only. The fair values of all of our debt obligations are categorized as Level 2 financial instruments. For further information on the fair values of our debt and the inputs used in the calculations, see Note 11, Debt .

Deferred Costs

Deferred Costs	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Deferred Costs	Deferred Costs Deferred costs, which consist of deferred sales commissions, were $734 million and $741 million as of October 31, 2024, and January 31, 2024, respectively. Amortization expense for the deferred costs was $64 million and $54 million for the three months ended October 31, 2024, and 2023, respectively, and $185 million and $155 million for the nine months ended October 31, 2024, and 2023, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. Contract Balances Contract assets and unearned revenue balances were as follows (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Contract assets: Contract assets, current Trade and other receivables, net $ 414 $ 240 Contract assets, noncurrent Other assets 37 21 Total contract assets $ 451 $ 261 Unearned revenue (1) : Unearned revenue, current Unearned revenue $ 3,447 $ 4,057 Unearned revenue, noncurrent Unearned revenue, noncurrent 64 70 Total unearned revenue $ 3,511 $ 4,127 (1) Included in the unearned revenue balance are amounts related to professional services that are subject to cancellation and pro-rated refund rights of $69 million and $76 million as of October 31, 2024, and January 31, 2024, respectively. Revenues of $1.6 billion and $1.4 billion were recognized during the three months ended October 31, 2024, and 2023, respectively, that were included in the unearned revenue balances as of July 31, 2024, and 2023, respectively. Revenues of $3.6 billion and $3.1 billion were recognized during the nine months ended October 31, 2024, and 2023, respectively, that were included in the unearned revenue balances as of January 31, 2024, and 2023, respectively. Transaction Price Allocated to the Remaining Performance Obligations As of October 31, 2024, approximately $22.2 billion of revenues are expected to be recognized from remaining performance obligations for subscription contracts. We expect to recognize revenues on approximately $7.0 billion and $12.3 billion of these remaining performance obligations over the next 12 and 24 months, respectively, with the balance recognized thereafter. Revenues from remaining performance obligations for professional services contracts as of October 31, 2024, were not material.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consisted of the following (in millions): October 31, 2024 January 31, 2024 Computers, equipment, and software $ 1,402 $ 1,387 Buildings 740 726 Leasehold improvements 245 213 Furniture, fixtures, and transportation equipment 105 99 Land and land improvements 81 81 Property and equipment, gross 2,573 2,506 Less accumulated depreciation and amortization (1,310) (1,272) Property and equipment, net $ 1,263 $ 1,234 Depreciation expense totaled $60 million and $52 million for the three months ended October 31, 2024, and 2023, respectively, and $174 million and $149 million for the nine months ended October 31, 2024, and 2023, respectively.

Business Combinations

Business Combinations	9 Months Ended
	Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combination	Business Combinations Evisort Acquisition On October 8, 2024, we acquired all outstanding stock of Evisort Inc. (“Evisort”), a provider of an AI-native document intelligence platform. With Evisort, we intend to add AI-powered document intelligence solutions across our suite of finance and HCM applications. We have included the financial results of Evisort in our condensed consolidated financial statements from the date of acquisition. The total acquisition-date fair value of the purchase consideration was $311 million, which was paid in cash. We recorded developed technology intangible assets of $44 million (to be amortized over an estimated useful life of 6 years), customer relationships intangible assets of $28 million (to be amortized over an estimated useful life of 14 years), and goodwill of $238 million. The goodwill recognized was primarily attributable to the expected synergies from integrating Evisort’s technology into our product portfolio. The goodwill is not deductible for income tax purposes. The fair values of assets acquired and liabilities assumed may be subject to change over the measurement period as additional information is received and certain tax matters are finalized. The measurement period will end no later than one year from the acquisition date. Separate operating results and pro forma results of operations for Evisort have not been presented as the effect of this acquisition was not material to our financial results. HiredScore Acquisition On March 29, 2024, we acquired all outstanding stock of HiredScore, Inc. (“HiredScore”), a provider of AI-powered talent orchestration solutions. With HiredScore, Workday provides customers with a comprehensive, transparent, and intelligent talent acquisition and internal mobility offering, helping them better address their ever-evolving people needs. We have included the financial results of HiredScore in our condensed consolidated financial statements from the date of acquisition. The total acquisition-date fair value of the purchase consideration was $530 million, which was paid in cash. The purchase consideration was preliminarily allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill. The fair values of assets acquired and liabilities assumed may be subject to change over the measurement period as additional information is received and certain tax matters are finalized. The primary areas that are subject to change include income taxes payable and deferred taxes. The measurement period will end no later than one year from the acquisition date. The preliminary fair values of the assets acquired and liabilities assumed as of the date of acquisition were as follows (in millions): Cash $ 11 Acquisition-related intangible assets 135 Goodwill 410 Other assets 12 Other liabilities (38) Total $ 530 The fair values and weighted-average useful lives of the acquired intangible assets by category were as follows (in millions, except years): Estimated Fair Values Weighted-Average Useful Lives (in Years) Developed technology $ 111 8 Customer relationships 23 14 Trade name 1 1 Total acquisition-related intangible assets $ 135 9 The goodwill recognized was primarily attributable to the assembled workforce and the expected synergies from integrating HiredScore’s technology into our product portfolio. The goodwill is not deductible for income tax purposes. Separate operating results and pro forma results of operations for HiredScore have not been presented as the effect of this acquisition was not material to our financial results.

Acquisition-Related Intangible

Acquisition-Related Intangible Assets, Net	9 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Acquisition-Related Intangible Assets, Net	Acquisition-Related Intangible Assets, Net Acquisition-related intangible assets, net consisted of the following as of October 31, 2024 (in millions): Gross Carrying Amount Accumulated Amortization Net Book Value Developed technology $ 473 $ (290) $ 183 Customer relationships 362 (163) 199 Backlog 15 (15) 0 Trade name 14 (13) 1 Total $ 864 $ (481) $ 383 Acquisition-related intangible assets, net consisted of the following as of January 31, 2024 (in millions): Gross Carrying Amount Accumulated Amortization Net Book Value Developed technology $ 318 $ (256) $ 62 Customer relationships 311 (140) 171 Backlog 15 (15) 0 Trade name 13 (13) 0 Total $ 657 $ (424) $ 233 Amortization expense related to acquisition-related intangible assets was $20 million and $16 million for the three months ended October 31, 2024, and 2023, respectively, and $58 million for each of the nine month periods ended October 31, 2024, and 2023. As of October 31, 2024, the future estimated amortization expense related to acquisition-related intangible assets was as follows (in millions): Fiscal Period: Remainder of 2025 $ 21 2026 82 2027 57 2028 53 2029 43 Thereafter 127 Total $ 383

Other Assets

Other Assets	9 Months Ended
	Oct. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets Other assets consisted of the following (in millions): October 31, 2024 January 31, 2024 Non-marketable equity and other investments $ 245 $ 248 Contract assets 37 21 Technology patents and other intangible assets, net 26 26 Prepayments for goods and services 16 14 Derivative assets 13 14 Deposits 10 8 Other 18 6 Total other assets $ 365 $ 337 Technology patents and other intangible assets with estimable useful lives are amortized on a straight-line basis. As of October 31, 2024, the future estimated amortization expense was as follows (in millions): Fiscal Period: Remainder of 2025 $ 1 2026 4 2027 3 2028 3 2029 3 Thereafter 12 Total $ 26

Derivative Instruments

Derivative Instruments	9 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments We conduct business on a global basis in multiple foreign currencies, subjecting Workday to foreign currency exchange risk. To mitigate this risk, we utilize derivative hedging contracts as described below. We do not enter into any derivatives for trading or speculative purposes. Our foreign currency contracts are classified within Level 2 of the fair value hierarchy because the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. Cash Flow Hedges We enter into foreign currency forward contracts to hedge a portion of our forecasted revenue and expense transactions (“cash flow hedges”). We designate these forward contracts as cash flow hedging instruments since the accounting criteria for such designation has been met. Cash flow hedges are recorded on the Condensed Consolidated Balance Sheets at fair value. Cash flows from the settlement of these forward contracts are classified as operating activities on the Condensed Consolidated Statements of Cash Flows. Gains or losses resulting from changes in the fair value of these hedges are recorded in Accumulated other comprehensive income (loss) (“AOCI”) on the Condensed Consolidated Balance Sheets and are subsequently reclassified to the same line item as the hedged transaction on the Condensed Consolidated Statements of Operations in the same period that the hedged transaction affects earnings. As of October 31, 2024, we estimate that $18 million of net gains recorded in AOCI related to our cash flow hedges will be reclassified into income within the next 12 months. As of October 31, 2024, and January 31, 2024, the notional values of the cash flow hedges that we held to buy U.S. dollars in exchange for other currencies were $2.8 billion and $2.5 billion, respectively, and the notional values of the cash flow hedges that we held to sell U.S. dollars in exchange for other currencies were $412 million and $399 million, respectively. All contracts had maturities of less than 60 months. Non-Designated Hedges We also enter into foreign currency forward contracts to hedge a portion of our net outstanding monetary assets and liabilities (“non-designated hedges”). These forward contracts are intended to offset foreign currency gains or losses associated with the underlying monetary assets and liabilities and are recorded on the Condensed Consolidated Balance Sheets at fair value. These forward contracts are not designated as hedging instruments under applicable accounting guidance, and therefore all changes in the fair value of these forward contracts are recorded in Other income (expense), net on the Condensed Consolidated Statements of Operations. Cash flows from the settlement of these forward contracts are classified as operating activities on the Condensed Consolidated Statements of Cash Flows. As of October 31, 2024, and January 31, 2024, the notional values of the non-designated hedges that we held to buy U.S. dollars in exchange for other currencies were $120 million and $237 million, respectively, and the notional values of the non-designated hedges that we held to sell U.S. dollars in exchange for other currencies were $54 million and $11 million, respectively. The fair values of outstanding derivative instruments were as follows (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Derivative assets: Cash flow hedges Prepaid expenses and other current assets $ 30 $ 30 Cash flow hedges Other assets 13 14 Non-designated hedges Prepaid expenses and other current assets 3 2 Total derivative assets $ 46 $ 46 Derivative liabilities: Cash flow hedges Accrued expenses and other current liabilities $ 12 $ 14 Cash flow hedges Other liabilities 12 12 Non-designated hedges Accrued expenses and other current liabilities 1 1 Total derivative liabilities $ 25 $ 27 The effect of cash flow hedges on the Condensed Consolidated Statements of Operations was as follows (in millions): Three Months Ended October 31, Condensed Consolidated Statements of Operations Location 2024 2023 Total Gains (losses) related to cash flow hedges Total Gains (losses) related to cash flow hedges Revenues $ 2,160 $ 7 $ 1,866 $ 16 Costs and expenses 1,995 3 1,778 1 Nine Months Ended October 31, Condensed Consolidated Statements of Operations Location 2024 2023 Total Gains (losses) related to cash flow hedges Total Gains (losses) related to cash flow hedges Revenues $ 6,235 $ 23 $ 5,337 $ 49 Costs and expenses 5,895 (2) 5,233 2 Pre-tax gains (losses) associated with cash flow hedges were as follows (in millions): Condensed Consolidated Statements of Operations and Statements of Comprehensive Income (Loss) Locations Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Gains (losses) recognized in OCI Net change in unrealized gains (losses) on cash flow hedges $ 0 $ 67 $ 11 $ 54 Gains (losses) reclassified from AOCI into income (effective portion) Revenues 7 16 23 49 Gains (losses) reclassified from AOCI into income (effective portion) Costs and expenses 3 1 (2) 2 Gains (losses) associated with non-designated hedges were as follows (in millions): Condensed Consolidated Statements of Operations Location Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Gains (losses) related to non-designated hedges Other income (expense), net $ 0 $ 6 $ (2) $ 8 We are subject to netting agreements with all of the counterparties of the foreign exchange contracts, under which we are permitted to net settle transactions of the same currency with a single net amount payable by one party to the other. It is our policy to present the derivatives gross on the Condensed Consolidated Balance Sheets. Our foreign currency forward contracts are not subject to any credit contingent features or collateral requirements. We manage our exposure to counterparty risk by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions. As of October 31, 2024, information related to these offsetting arrangements was as follows (in millions): Gross Amounts of Recognized Assets Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Assets Exposed Financial Instruments Cash Collateral Received Derivative assets: Counterparty A $ 13 $ 0 $ 13 $ (4) $ 0 $ 9 Counterparty B 9 0 9 (6) 0 3 Counterparty C 3 0 3 (1) 0 2 Counterparty D 17 0 17 (13) 0 4 Counterparty E 1 0 1 0 0 1 Counterparty F 2 0 2 (1) 0 1 Counterparty G 1 0 1 0 0 1 Total $ 46 $ 0 $ 46 $ (25) $ 0 $ 21 Gross Amounts of Recognized Liabilities Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Liabilities Exposed Financial Instruments Cash Collateral Pledged Derivative liabilities: Counterparty A $ 4 $ 0 $ 4 $ (4) $ 0 $ 0 Counterparty B 6 0 6 (6) 0 0 Counterparty C 1 0 1 (1) 0 0 Counterparty D 13 0 13 (13) 0 0 Counterparty F 1 0 1 (1) 0 0 Total $ 25 $ 0 $ 25 $ (25) $ 0 $ 0

Debt

Debt	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt Outstanding debt consisted of the following (in millions): October 31, 2024 January 31, 2024 2027 Notes $ 1,000 $ 1,000 2029 Notes 750 750 2032 Notes 1,250 1,250 Total principal amount 3,000 3,000 Less: unamortized debt discount and issuance costs (17) (20) Debt, noncurrent $ 2,983 $ 2,980 As of October 31, 2024, the future principal payments for the outstanding debt were as follows (in millions): Fiscal Period: Remainder of 2025 $ 0 2026 0 2027 0 2028 1,000 2029 0 Thereafter 2,000 Total principal amount $ 3,000 Senior Notes In April 2022, we issued $3.0 billion aggregate principal amount of senior notes, consisting of $1.0 billion aggregate principal amount of 3.500% notes due April 1, 2027 (“2027 Notes”), $750 million aggregate principal amount of 3.700% notes due April 1, 2029 (“2029 Notes”), and $1.25 billion aggregate principal amount of 3.800% notes due April 1, 2032 (“2032 Notes,” and together with the 2027 Notes and the 2029 Notes, “Senior Notes”). Interest is payable semi-annually in arrears on April 1 and October 1 of each year. The Senior Notes are unsecured obligations and rank equally with all existing and future unsecured and unsubordinated indebtedness of Workday. We may redeem the Senior Notes in whole or in part at any time or from time to time, at specified redemption dates and prices. In addition, upon the occurrence of certain change of control triggering events, we may be required to repurchase the Senior Notes under specified terms. The indenture governing the Senior Notes also includes covenants (including certain limited covenants restricting our ability to incur certain liens and enter into certain sale and leaseback transactions), events of default, and other customary provisions. As of October 31, 2024, and January 31, 2024, we were in compliance with all covenants associated with the Senior Notes. We incurred debt discount and issuance costs of approximately $27 million in connection with the Senior Notes offering, which were allocated on a pro rata basis to the 2027 Notes, 2029 Notes, and 2032 Notes. The debt discount and issuance costs are amortized on a straight-line basis, which approximates the effective interest rate method, to interest expense over the contractual term of each arrangement. The effective interest rates on the 2027 Notes, 2029 Notes, and 2032 Notes, which are calculated as the contractual interest rates adjusted for the debt discount and issuance costs, are 3.67%, 3.82%, and 3.90%, respectively. As of both October 31, 2024, and January 31, 2024, the total estimated fair value of the Senior Notes was $2.8 billion. The estimated fair values of the Senior Notes, which we have classified as Level 2 financial instruments, were determined based on quoted bid prices in an over-the-counter market on the last trading day of the reporting period. Credit Agreement In April 2022, we entered into a credit agreement (“2022 Credit Agreement”) which provides for a revolving credit facility in an aggregate principal amount of $1.0 billion. As of October 31, 2024, we had no outstanding revolving loans under the 2022 Credit Agreement. The revolving loans under the 2022 Credit Agreement may be borrowed, repaid, and reborrowed until April 6, 2027, at which time all amounts borrowed must be repaid. The revolving loans under the 2022 Credit Agreement will bear interest, at our option, at a base rate plus a margin of 0.000% to 0.500% or a secured overnight financing rate (“SOFR”) plus 10 basis points, plus a margin of 0.750% to 1.500%, with such margin being determined based on our consolidated leverage ratio or debt rating. We are also obligated to pay an ongoing commitment fee on undrawn amounts. The 2022 Credit Agreement contains customary representations, warranties, and affirmative and negative covenants, including a financial covenant, events of default, and indemnification provisions in favor of the lenders. The negative covenants include restrictions on the incurrence of liens and indebtedness, certain merger transactions, and other matters, all subject to certain exceptions. The financial covenant, based on a quarterly financial test, requires that we do not exceed a maximum leverage ratio of 3.50:1.00, subject to a step-up to 4.50:1.00 at our election for a certain period following an acquisition. As of October 31, 2024, and January 31, 2024, we were in compliance with all covenants included in the 2022 Credit Agreement. Interest Expense on Debt The following table sets forth the interest expense recognized related to our debt (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Contractual interest expense $ 28 $ 28 $ 83 $ 83 Interest cost related to amortization of debt discount and issuance costs 1 1 3 3 Total interest expense $ 29 $ 29 $ 86 $ 86

Leases

Leases	9 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Leases	Leases We have entered into operating lease agreements for our office space, data centers, and other property and equipment. Operating lease right-of-use assets were $335 million and $289 million as of October 31, 2024, and January 31, 2024, respectively, and operating lease liabilities were $380 million and $316 million as of October 31, 2024, and January 31, 2024, respectively. The components of operating lease expense were as follows (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Operating lease cost $ 30 $ 27 $ 88 $ 82 Short-term lease cost 0 1 1 2 Variable lease cost 15 12 39 34 Total operating lease cost $ 45 $ 40 $ 128 $ 118 Supplemental cash flow information related to our operating leases was as follows (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Cash paid for operating lease liabilities $ 29 $ 25 $ 80 $ 79 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities 22 30 123 94 Other information related to our operating leases was as follows: October 31, 2024 January 31, 2024 Weighted average remaining lease term (in years) 5 5 Weighted average discount rate 4.07 % 3.95 % As of October 31, 2024, maturities of operating lease liabilities were as follows (in millions): Fiscal Period: Remainder of 2025 $ 30 2026 108 2027 88 2028 77 2029 49 Thereafter 78 Total lease payments 430 Less imputed interest (50) Total operating lease liabilities $ 380 As of October 31, 2024 , we have additional operating leases for data centers and office space that had not yet commenced with total undiscounted lease payments of $90 million. These operating leases will commence in fiscal 2025 and fiscal 2026, with lease terms ranging from approximately five

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Obligations Our purchase obligations are primarily related to agreements for third-party hosted infrastructure platforms, data center equipment and software, business technology software and support, and sales and marketing activities. During the nine months ended October 31, 2024, there were no material changes outside the ordinary course of business to our non-cancelable purchase obligations disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024. Legal Matters We are a party to various legal proceedings and claims that arise in the ordinary course of business. We make a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular matter. In our opinion, as of October 31, 2024, there was not at least a reasonable possibility that we had incurred a material loss, or a material loss in excess of a recorded accrual, with respect to such loss contingencies.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock As of October 31, 2024, there were 213 million shares of Class A common stock, net of treasury stock, and 52 million shares of Class B common stock outstanding. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to 10 votes per share. Each share of Class B common stock can be converted into a share of Class A common stock at any time at the option of the holder. Share Repurchase Programs In August 2024, our Board of Directors authorized the repurchase of up to $1.0 billion of our outstanding shares of Class A common stock (“August 2024 Share Repurchase Program”). Under this program, in accordance with applicable securities laws and other restrictions, we may repurchase shares of our Class A common stock through open market purchases, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act, in privately negotiated transactions, or by other means. The timing and total amount of share repurchases will depend upon business, economic, and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The August 2024 Share Repurchase Program has no expiration date, may be suspended or discontinued at any time, and does not obligate us to acquire any amount of Class A common stock. Prior to the August 2024 Share Repurchase Program, our Board of Directors authorized a $500 million share repurchase program in February 2024, which we completed in the third quarter of fiscal 2025, and a $500 million share repurchase program in November 2022, which we completed in the first quarter of fiscal 2025. The table below sets forth information regarding our share repurchase programs (in millions, except number of shares which are reflected in thousands, and per share data): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Total number of shares repurchased 649 677 2,538 1,312 Average price paid per share $ 242.42 $ 218.35 $ 236.73 $ 218.34 Amount repurchased $ 157 $ 147 $ 600 $ 286 All repurchases were made in open market transactions. As of October 31, 2024, we were authorized to repurchase a remaining $902 million of our outstanding shares of Class A common stock under the August 2024 Share Repurchase Program. Employee Equity Plans In June 2022, our stockholders approved the 2022 Equity Incentive Plan (“2022 Plan”), with a reserve of 30 million shares for issuance. The 2022 Plan serves as the successor to our 2012 Equity Incentive Plan (“2012 Plan” and, together with the 2022 Plan, “Stock Plans”). Awards that are granted on or after the effective date of the 2022 Plan will be granted pursuant to and subject to the terms and provisions of the 2022 Plan. Prior awards granted under the 2012 Plan continue to be subject to the terms and provisions of the 2012 Plan. Shares that are withheld in connection with the net share settlement of RSUs or forfeited are added to the reserves of the 2022 Plan. As of October 31, 2024, we had 17 million shares of Class A common stock available for future grants. In June 2022, our stockholders approved the Amended and Restated 2012 Employee Stock Purchase Plan (“ESPP”). Under the ESPP, eligible employees are granted options to purchase shares at the lower of 85% of the fair market value of the stock at the time of grant or 85% of the fair market value at the time of exercise. Options to purchase shares are granted twice yearly on or about June 1 and December 1, and are exercisable on or about the succeeding November 30 and May 31, respectively. As of October 31, 2024, 3 million shares of Class A common stock were available for issuance under the ESPP. Restricted Stock Units The Stock Plans provide for the issuance of restricted stock units (“RSUs”) to employees and non-employees. RSUs generally vest over four years. RSU activity during the nine months ended October 31, 2024, was as follows (in thousands, except per share data): Number of Shares Weighted-Average Grant Date Fair Value Outstanding balance as of January 31, 2024 15,020 $ 203.94 RSUs granted 6,602 251.96 RSUs vested (3,495) 203.45 RSUs forfeited and canceled (1) (2,854) 206.65 Outstanding balance as of October 31, 2024 15,273 224.31 (1) Includes shares withheld in connection with the net share settlement of RSUs. As of October 31, 2024, there was a total of $2.6 billion in unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested RSUs, which is expected to be recognized over a weighted-average period of approximately three years. Market-Based Restricted Stock Units In December 2022, 0.3 million shares of market-based RSUs were granted to Mr. Eschenbach in connection with his appointment as Co-CEO that vest based on appreciation of the price of our Class A common stock over a multi-year period and upon continued service (“PVU Award”). We estimated the fair value of the PVU Award on the grant date using the Monte Carlo simulation model with the following assumptions: (i) expected volatility of 40%, (ii) risk-free interest rate of 4%, and (iii) total performance period of six years. The weighted-average grant date fair value of the PVU Award was $124.80 per share. We recognize expense for the PVU Award over the requisite service period of five years using the accelerated attribution method. Provided that the requisite service is rendered, the total fair value of the PVU Award at the date of grant is recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the achievement of the specified market criteria. As of October 31, 2024, there was a total of $11 million in unrecognized compensation cost related to the PVU Award, which is expected to be recognized over approximately three years. Stock Options The Stock Plans provide for the issuance of incentive and nonstatutory stock options to employees and non-employees. Stock options issued under the Stock Plans generally are exercisable for periods not to exceed ten years and generally vest over five years. As of October 31, 2024, there were 0.1 million options outstanding and exercisable with a weighted-average exercise price of $29.43, and an aggregate intrinsic value of $16 million. All stock options were fully vested, with no remaining unrecognized compensation cost.

Contract Balances and Performan

Contract Balances and Performance Obligations	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Contract Balances and Performance Obligations	Deferred Costs Deferred costs, which consist of deferred sales commissions, were $734 million and $741 million as of October 31, 2024, and January 31, 2024, respectively. Amortization expense for the deferred costs was $64 million and $54 million for the three months ended October 31, 2024, and 2023, respectively, and $185 million and $155 million for the nine months ended October 31, 2024, and 2023, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. Contract Balances Contract assets and unearned revenue balances were as follows (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Contract assets: Contract assets, current Trade and other receivables, net $ 414 $ 240 Contract assets, noncurrent Other assets 37 21 Total contract assets $ 451 $ 261 Unearned revenue (1) : Unearned revenue, current Unearned revenue $ 3,447 $ 4,057 Unearned revenue, noncurrent Unearned revenue, noncurrent 64 70 Total unearned revenue $ 3,511 $ 4,127 (1) Included in the unearned revenue balance are amounts related to professional services that are subject to cancellation and pro-rated refund rights of $69 million and $76 million as of October 31, 2024, and January 31, 2024, respectively. Revenues of $1.6 billion and $1.4 billion were recognized during the three months ended October 31, 2024, and 2023, respectively, that were included in the unearned revenue balances as of July 31, 2024, and 2023, respectively. Revenues of $3.6 billion and $3.1 billion were recognized during the nine months ended October 31, 2024, and 2023, respectively, that were included in the unearned revenue balances as of January 31, 2024, and 2023, respectively. Transaction Price Allocated to the Remaining Performance Obligations As of October 31, 2024, approximately $22.2 billion of revenues are expected to be recognized from remaining performance obligations for subscription contracts. We expect to recognize revenues on approximately $7.0 billion and $12.3 billion of these remaining performance obligations over the next 12 and 24 months, respectively, with the balance recognized thereafter. Revenues from remaining performance obligations for professional services contracts as of October 31, 2024, were not material.

Other Income (Expense), Net

Other Income (Expense), Net	9 Months Ended
	Oct. 31, 2024
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other Income (Expense), Net Other income (expense), net consisted of the following (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Interest income $ 86 $ 80 $ 267 $ 214 Interest expense (1) (29) (29) (86) (86) Other (2) 5 (10) (3) (14) Total other income (expense), net $ 62 $ 41 $ 178 $ 114 (1) Interest expense primarily includes the contractual interest expense of our debt obligations, and the related non-cash interest expense attributable to amortization of the debt discount and issuance costs. For further information, see Note 11, Debt . (2) Other primarily includes the net gains (losses) from our equity investments. For further information, see Note 3, Investments .

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We reported an income tax provision of $86 million and $25 million for the nine months ended October 31, 2024, and 2023, respectively. The income tax provision for the nine months ended October 31, 2024, was primarily attributable to earnings in the U.S. and profitable foreign jurisdictions, offset by the excess tax benefit from stock-based compensation and increase in research and development credits. The income tax provision for the nine months ended October 31, 2023, was primarily attributable to income tax expenses in profitable foreign jurisdictions and an increase in U.S. taxes due to capitalized research and development expenditures. We are subject to income tax audits in the U.S. and foreign jurisdictions. We record liabilities related to uncertain tax positions and believe that we have provided adequate reserves for income tax uncertainties in all open tax years. Due to our history of tax losses, all years remain open to tax audit. We periodically evaluate the realizability of our net deferred tax assets based on all available evidence, both positive and negative. The realization of net deferred tax assets is dependent on our ability to generate sufficient future taxable income during periods prior to the expiration of tax attributes to fully utilize these assets. As of October 31, 2024, we continue to maintain valuation allowances related to tax credits in certain state jurisdictions and net operating loss in certain foreign jurisdictions. We will continue to evaluate the need for valuation allowances for our deferred tax assets.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period, net of treasury stock. Diluted net income (loss) per share is computed by giving effect to all potentially dilutive shares of common stock, including outstanding share-based awards consisting primarily of unvested RSUs and ESPP obligations and outstanding warrants related to the issuance of convertible senior notes. We determine the dilutive effect of outstanding share-based awards and warrants using the treasury stock method. The net income (loss) per share is allocated based on the contractual participation rights of the Class A common shares and Class B common shares as if the income (loss) for the period had been distributed. As the liquidation and dividend rights are identical, the net income (loss) is allocated on a proportionate basis. The computation of the diluted net income per share of Class A common stock assumes the conversion of our Class B common stock to Class A common stock, while the diluted net income (loss) per share of Class B common stock does not assume the conversion of those shares. The following table presents the calculation of basic and diluted net income (loss) per share (in millions, except number of shares, which are reflected in thousands, and per share data): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Net income (loss) per share, basic: Numerator: Net income (loss) $ 155 $ 38 $ 90 $ 24 $ 346 $ 86 $ 152 $ 41 Denominator: Weighted-average shares outstanding, basic 213,047 52,364 207,726 54,427 212,350 52,712 206,184 54,563 Net income (loss) per share, basic $ 0.73 $ 0.73 $ 0.43 $ 0.43 $ 1.63 $ 1.63 $ 0.74 $ 0.74 Net income (loss) per share, diluted: Numerator: Net income (loss) $ 155 $ 38 $ 90 $ 24 $ 346 $ 86 $ 152 $ 41 Reallocation of net income as a result of conversion of Class B to Class A common stock 38 0 24 0 86 0 41 0 Reallocation of net income to Class B common stock 0 0 0 (1) 0 (1) 0 (1) Net income (loss) for diluted calculation 193 38 114 23 432 85 193 40 Denominator: Weighted-average shares outstanding, basic 213,047 52,364 207,726 54,427 212,350 52,712 206,184 54,563 Conversion of Class B to Class A common stock 52,364 0 54,427 0 52,712 0 54,563 0 Dilutive effect of share-based awards 3,138 0 4,224 0 3,874 0 3,340 0 Weighted-average shares outstanding, diluted 268,549 52,364 266,377 54,427 268,936 52,712 264,087 54,563 Net income (loss) per share, diluted $ 0.72 $ 0.72 $ 0.43 $ 0.43 $ 1.61 $ 1.61 $ 0.73 $ 0.73 The computation of diluted net income (loss) per share does not include the effect of the following potentially outstanding weighted-average shares of common stock. The effects of these potentially outstanding shares were not included in the calculation of diluted net income (loss) per share because the effect would have been anti-dilutive (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Total weighted-average shares related to outstanding share-based awards 258 1,882 2,217 2,774

Geographic Information

Geographic Information	9 Months Ended
	Oct. 31, 2024
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenues We sell our subscription contracts and related services in two primary geographical markets: to customers located in the United States and to customers located outside of the United States. Revenues by geography are generally based on the address of the customer as specified in our customer subscription agreement. The following table sets forth revenues by geographic area (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 United States $ 1,623 $ 1,404 $ 4,676 $ 4,013 Other countries 537 462 1,559 1,324 Total revenues $ 2,160 $ 1,866 $ 6,235 $ 5,337 Long-Lived Assets Our long-lived assets are attributed to a country based on the physical location of the assets. We define long-lived assets as property and equipment and operating lease right-of-use assets because many of these assets cannot be readily moved and are relatively illiquid, subjecting them to geographic risk. None of our other assets are subject to significant geographic risk. Aggregate Property and equipment, net and Operating lease right-of-use assets by geographic area was as follows (in millions): October 31, 2024 January 31, 2024 United States $ 1,226 $ 1,199 Ireland 234 213 Other countries 138 111 Total long-lived assets $ 1,598 $ 1,523

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 193	$ 114	$ 432	$ 193

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Oct. 31, 2024 shares	Oct. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the three months ended October 31, 2024, the following directors and/or officers of Workday adopted or terminated a “Rule 10b5-1 trading arrangement,” as defined in item 408(a) of Regulation S-K intending to satisfy the affirmative defense of Rule 10b5-1(c): Name and Title Action Total Shares of Class A Common Stock to be Sold Adoption Date Expiration Date Sayan Chakraborty, Co-President Adopt 54,543 (1) October 4, 2024 December 31, 2025 Carl Eschenbach, Chief Executive Officer and Director (2) Adopt 25,000 October 7, 2024 December 31, 2025 Mark Garfield, Chief Accounting Officer Adopt 7,595 (1) October 12, 2024 January 14, 2026 (1) Includes shares to be withheld by Workday in mandatory transactions to cover withholding taxes in connection with the settlement of equity awards. (2)
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Sayan Chakraborty [Member]
Trading Arrangements, by Individual
Name	Sayan Chakraborty
Title	Co-President
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 4, 2024
Expiration Date	December 31, 2025
Arrangement Duration	453 days
Aggregate Available	54,543	54,543
Carl Eschenbach [Member]
Trading Arrangements, by Individual
Name	Carl Eschenbach
Title	Chief Executive Officer and Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 7, 2024
Expiration Date	December 31, 2025
Arrangement Duration	450 days
Aggregate Available	25,000	25,000
Mark Garfield [Member]
Trading Arrangements, by Individual
Name	Mark Garfield
Title	Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 12, 2024
Expiration Date	January 14, 2026
Arrangement Duration	459 days
Aggregate Available	7,595	7,595

Significant Accounting Polici_2

Significant Accounting Policies and Accounting Standards (Policies)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated financial statements include the results of Workday, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of our management, the information contained herein reflects all adjustments necessary for a fair presentation of Workday’s financial position, results of operations, stockholders’ equity, and cash flows. All such adjustments are of a normal, recurring nature. The results of operations for the three and nine months ended October 31, 2024, shown in this report are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2025. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024, filed with the SEC on March 8, 2024. Certain prior period amounts reported in our unaudited condensed consolidated financial statements and notes thereto have been reclassified to conform to current period presentation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates, judgments, and assumptions include, but are not limited to, the identification of distinct performance obligations for revenue recognition, the determination of the period of benefit for deferred commissions, the realizability of deferred tax assets, the measurement of uncertain tax positions, the fair value and useful lives of assets acquired and liabilities assumed through business combinations, and the valuation of non-marketable equity investments. Actual results could differ from those estimates, judgments, and assumptions, and such differences could be material to our condensed consolidated financial statements.
Segment Information	Segment Information We operate in one operating segment, cloud applications. Operating segments are defined as components of an enterprise where separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assessing performance. Our CODM, the Chief Executive Officer, allocates resources and assesses performance based upon discrete financial information at the consolidated level.
Concentrations of Risk and Significant Customers	Concentrations of Risk and Significant Customers Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities, derivative instruments, and trade and other receivables. Our deposits exceed federally insured limits. In order to reduce the risk of disruption of our cloud applications, we have established data centers in various geographic regions. We serve our customers and users from data center facilities operated by third parties, located in North America and Europe. We have internal procedures to restore services in the event of disruption at one of our data center facilities. Even with these procedures for disaster recovery in place, our cloud applications could be significantly interrupted during the implementation of the procedures to restore services. In addition, we rely upon third-party hosted infrastructure partners, including Amazon Web Services (“AWS”) and Google LLC, to serve customers globally and operate certain aspects of our services. Given this, any disruption of or interference at our hosted infrastructure partners may impact our operations and our business could be adversely impacted.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The standard requires retrospective application to all prior periods presented in the financial statements. We are currently evaluating the impacts of the new standard. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The standard allows for adoption on a prospective basis, with a retrospective option. We do not intend to early adopt, and are currently evaluating the impacts of the new standard. In November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires the disclosure of additional information about specific expense categories in the notes to the financial statements. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The standard allows for adoption on a prospective or retrospective basis. We are currently evaluating the impacts of the new standard.
Investments	We classify our debt securities as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. We consider all debt securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classify these securities as current assets on the Condensed Consolidated Balance Sheets. Debt securities included in Marketable securities on the Condensed Consolidated Balance Sheets consist of securities with original maturities at the time of purchase greater than three months, and the remaining securities are included in Cash and cash equivalents.
Fair Value Measurements	We use a fair value hierarchy that requires that we maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: Level 1 — Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 — Other inputs that are directly or indirectly observable in the marketplace. Level 3 — Unobservable inputs that are supported by little or no market activity.
Derivative Instruments	We conduct business on a global basis in multiple foreign currencies, subjecting Workday to foreign currency exchange risk. To mitigate this risk, we utilize derivative hedging contracts as described below. We do not enter into any derivatives for trading or speculative purposes. Our foreign currency contracts are classified within Level 2 of the fair value hierarchy because the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. Cash Flow Hedges We enter into foreign currency forward contracts to hedge a portion of our forecasted revenue and expense transactions (“cash flow hedges”). We designate these forward contracts as cash flow hedging instruments since the accounting criteria for such designation has been met. We also enter into foreign currency forward contracts to hedge a portion of our net outstanding monetary assets and liabilities (“non-designated hedges”). These forward contracts are intended to offset foreign currency gains or losses associated with the underlying monetary assets and liabilities and are recorded on the Condensed Consolidated Balance Sheets at fair value. These forward contracts are not designated as hedging instruments under applicable accounting guidance, and therefore all changes in the fair value of these forward contracts are recorded in Other income (expense), net on the Condensed Consolidated Statements of Operations. Cash flows from the settlement of these forward contracts are classified as operating activities on the Condensed Consolidated Statements of Cash Flows. We are subject to netting agreements with all of the counterparties of the foreign exchange contracts, under which we are permitted to net settle transactions of the same currency with a single net amount payable by one party to the other. It is our policy to present the derivatives gross on the Condensed Consolidated Balance Sheets. Our foreign currency forward contracts are not subject to any credit contingent features or collateral requirements. We manage our exposure to counterparty risk by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions.
Net Income (Loss) Per Share	Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period, net of treasury stock. Diluted net income (loss) per share is computed by giving effect to all potentially dilutive shares of common stock, including outstanding share-based awards consisting primarily of unvested RSUs and ESPP obligations and outstanding warrants related to the issuance of convertible senior notes. We determine the dilutive effect of outstanding share-based awards and warrants using the treasury stock method. The net income (loss) per share is allocated based on the contractual participation rights of the Class A common shares and Class B common shares as if the income (loss) for the period had been distributed. As the liquidation and dividend rights are identical, the net income (loss) is allocated on a proportionate basis. The computation of the diluted net income per share of Class A common stock assumes the conversion of our Class B common stock to Class A common stock, while the diluted net income (loss) per share of Class B common stock does not assume the conversion of those shares.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Oct. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Summary of Debt Securities	As of October 31, 2024, debt securities consisted of the following (in millions): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 1,660 $ 5 $ (1) $ 1,664 U.S. agency obligations 694 2 0 696 Corporate bonds 3,058 12 (2) 3,068 Commercial paper 566 0 0 566 Total debt securities $ 5,978 $ 19 $ (3) $ 5,994 Included in Cash and cash equivalents $ 148 $ 0 $ 0 $ 148 Included in Marketable securities $ 5,830 $ 19 $ (3) $ 5,846 As of January 31, 2024, debt securities consisted of the following (in millions): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 2,072 $ 4 $ (2) $ 2,074 U.S. agency obligations 753 2 (1) 754 Corporate bonds 2,496 9 (5) 2,500 Commercial paper 1,232 0 0 1,232 Total debt securities $ 6,553 $ 15 $ (8) $ 6,560 Included in Cash and cash equivalents $ 759 $ 0 $ 0 $ 759 Included in Marketable securities $ 5,794 $ 15 $ (8) $ 5,801
Contractual Maturity of Debt Securities	The fair values of debt securities, by remaining contractual maturity, were as follows (in millions): October 31, 2024 Due within 1 year $ 2,983 Due in 1 year through 5 years 3,011 Total debt securities $ 5,994
Aggregate Fair Value and Gross Unrealized Losses for Debt Securities In Unrealized Loss Position	The following tables summarize the aggregate fair value and gross unrealized losses for all debt securities in an unrealized loss position, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions): As of October 31, 2024 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 266 $ (1) $ 120 $ 0 $ 386 $ (1) U.S. agency obligations 142 0 15 0 157 0 Corporate bonds 640 (2) 184 0 824 (2) Total $ 1,048 $ (3) $ 319 $ 0 $ 1,367 $ (3) As of January 31, 2024 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury securities $ 921 $ (2) $ 78 $ (1) $ 999 $ (3) U.S. agency obligations 234 0 100 (1) 334 (1) Corporate bonds 921 (3) 171 (1) 1,092 (4) Commercial paper 5 0 0 0 5 0 Total $ 2,081 $ (5) $ 349 $ (3) $ 2,430 $ (8)
Equity Investments	Equity investments consisted of the following (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Money market funds Cash and cash equivalents $ 849 $ 1,017 Non-marketable equity investments measured using the measurement alternative Other assets 242 248 Total equity investments $ 1,091 $ 1,265
Realized and Unrealized Gains and Losses With Equity Investments	Total realized and unrealized gains and losses associated with our equity investments were as follows (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Net realized gains (losses) recognized on equity investments sold (1) $ 0 $ (1) $ (3) $ 2 Net unrealized gains (losses) recognized on equity investments held as of the end of the period 3 (13) (4) (24) Total net gains (losses) recognized in Other income (expense), net $ 3 $ (14) $ (7) $ (22) (1) Reflects the difference between the sale proceeds and the carrying value of the equity investments at the beginning of the period.
Carrying Values Of Non-marketable Equity Investments	The carrying values for our non-marketable equity investments are summarized below (in millions): October 31, 2024 January 31, 2024 Total initial cost $ 210 $ 213 Cumulative net unrealized gains (losses) 32 35 Carrying value $ 242 $ 248

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Information about Assets Measured at Fair Value on a Recurring Basis	The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of October 31, 2024 (in millions): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 1,664 $ 0 $ 0 $ 1,664 U.S. agency obligations 0 696 0 696 Corporate bonds 0 3,068 0 3,068 Commercial paper 0 566 0 566 Money market funds 849 0 0 849 Foreign currency derivative assets 0 46 0 46 Total assets $ 2,513 $ 4,376 $ 0 $ 6,889 Foreign currency derivative liabilities $ 0 $ 25 $ 0 $ 25 Total liabilities $ 0 $ 25 $ 0 $ 25 The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of January 31, 2024 (in millions): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 2,074 $ 0 $ 0 $ 2,074 U.S. agency obligations 0 754 0 754 Corporate bonds 0 2,500 0 2,500 Commercial paper 0 1,232 0 1,232 Money market funds 1,017 0 0 1,017 Foreign currency derivative assets 0 46 0 46 Total assets $ 3,091 $ 4,532 $ 0 $ 7,623 Foreign currency derivative liabilities $ 0 $ 27 $ 0 $ 27 Total liabilities $ 0 $ 27 $ 0 $ 27

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment, net consisted of the following (in millions): October 31, 2024 January 31, 2024 Computers, equipment, and software $ 1,402 $ 1,387 Buildings 740 726 Leasehold improvements 245 213 Furniture, fixtures, and transportation equipment 105 99 Land and land improvements 81 81 Property and equipment, gross 2,573 2,506 Less accumulated depreciation and amortization (1,310) (1,272) Property and equipment, net $ 1,263 $ 1,234

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Summary of Preliminary Purchase Consideration Allocation	The preliminary fair values of the assets acquired and liabilities assumed as of the date of acquisition were as follows (in millions): Cash $ 11 Acquisition-related intangible assets 135 Goodwill 410 Other assets 12 Other liabilities (38) Total $ 530
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The fair values and weighted-average useful lives of the acquired intangible assets by category were as follows (in millions, except years): Estimated Fair Values Weighted-Average Useful Lives (in Years) Developed technology $ 111 8 Customer relationships 23 14 Trade name 1 1 Total acquisition-related intangible assets $ 135 9

Acquisition-Related Intangibl_2

Acquisition-Related Intangible Assets, Net (Tables)	9 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Assets	Acquisition-related intangible assets, net consisted of the following as of October 31, 2024 (in millions): Gross Carrying Amount Accumulated Amortization Net Book Value Developed technology $ 473 $ (290) $ 183 Customer relationships 362 (163) 199 Backlog 15 (15) 0 Trade name 14 (13) 1 Total $ 864 $ (481) $ 383 Acquisition-related intangible assets, net consisted of the following as of January 31, 2024 (in millions): Gross Carrying Amount Accumulated Amortization Net Book Value Developed technology $ 318 $ (256) $ 62 Customer relationships 311 (140) 171 Backlog 15 (15) 0 Trade name 13 (13) 0 Total $ 657 $ (424) $ 233
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of October 31, 2024, the future estimated amortization expense related to acquisition-related intangible assets was as follows (in millions): Fiscal Period: Remainder of 2025 $ 21 2026 82 2027 57 2028 53 2029 43 Thereafter 127 Total $ 383 Fiscal Period: Remainder of 2025 $ 1 2026 4 2027 3 2028 3 2029 3 Thereafter 12 Total $ 26

Other Assets (Tables)

Other Assets (Tables)	9 Months Ended
	Oct. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Assets	Other assets consisted of the following (in millions): October 31, 2024 January 31, 2024 Non-marketable equity and other investments $ 245 $ 248 Contract assets 37 21 Technology patents and other intangible assets, net 26 26 Prepayments for goods and services 16 14 Derivative assets 13 14 Deposits 10 8 Other 18 6 Total other assets $ 365 $ 337
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of October 31, 2024, the future estimated amortization expense related to acquisition-related intangible assets was as follows (in millions): Fiscal Period: Remainder of 2025 $ 21 2026 82 2027 57 2028 53 2029 43 Thereafter 127 Total $ 383 Fiscal Period: Remainder of 2025 $ 1 2026 4 2027 3 2028 3 2029 3 Thereafter 12 Total $ 26

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Values of Outstanding Derivative Instruments	The fair values of outstanding derivative instruments were as follows (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Derivative assets: Cash flow hedges Prepaid expenses and other current assets $ 30 $ 30 Cash flow hedges Other assets 13 14 Non-designated hedges Prepaid expenses and other current assets 3 2 Total derivative assets $ 46 $ 46 Derivative liabilities: Cash flow hedges Accrued expenses and other current liabilities $ 12 $ 14 Cash flow hedges Other liabilities 12 12 Non-designated hedges Accrued expenses and other current liabilities 1 1 Total derivative liabilities $ 25 $ 27
Derivative Instruments Gain (Loss)	The effect of cash flow hedges on the Condensed Consolidated Statements of Operations was as follows (in millions): Three Months Ended October 31, Condensed Consolidated Statements of Operations Location 2024 2023 Total Gains (losses) related to cash flow hedges Total Gains (losses) related to cash flow hedges Revenues $ 2,160 $ 7 $ 1,866 $ 16 Costs and expenses 1,995 3 1,778 1 Nine Months Ended October 31, Condensed Consolidated Statements of Operations Location 2024 2023 Total Gains (losses) related to cash flow hedges Total Gains (losses) related to cash flow hedges Revenues $ 6,235 $ 23 $ 5,337 $ 49 Costs and expenses 5,895 (2) 5,233 2 Pre-tax gains (losses) associated with cash flow hedges were as follows (in millions): Condensed Consolidated Statements of Operations and Statements of Comprehensive Income (Loss) Locations Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Gains (losses) recognized in OCI Net change in unrealized gains (losses) on cash flow hedges $ 0 $ 67 $ 11 $ 54 Gains (losses) reclassified from AOCI into income (effective portion) Revenues 7 16 23 49 Gains (losses) reclassified from AOCI into income (effective portion) Costs and expenses 3 1 (2) 2 Gains (losses) associated with non-designated hedges were as follows (in millions): Condensed Consolidated Statements of Operations Location Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Gains (losses) related to non-designated hedges Other income (expense), net $ 0 $ 6 $ (2) $ 8
Offsetting Assets	As of October 31, 2024, information related to these offsetting arrangements was as follows (in millions): Gross Amounts of Recognized Assets Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Assets Exposed Financial Instruments Cash Collateral Received Derivative assets: Counterparty A $ 13 $ 0 $ 13 $ (4) $ 0 $ 9 Counterparty B 9 0 9 (6) 0 3 Counterparty C 3 0 3 (1) 0 2 Counterparty D 17 0 17 (13) 0 4 Counterparty E 1 0 1 0 0 1 Counterparty F 2 0 2 (1) 0 1 Counterparty G 1 0 1 0 0 1 Total $ 46 $ 0 $ 46 $ (25) $ 0 $ 21
Offsetting Liabilities	As of October 31, 2024, information related to these offsetting arrangements was as follows (in millions): Gross Amounts of Recognized Liabilities Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Liabilities Exposed Financial Instruments Cash Collateral Pledged Derivative liabilities: Counterparty A $ 4 $ 0 $ 4 $ (4) $ 0 $ 0 Counterparty B 6 0 6 (6) 0 0 Counterparty C 1 0 1 (1) 0 0 Counterparty D 13 0 13 (13) 0 0 Counterparty F 1 0 1 (1) 0 0 Total $ 25 $ 0 $ 25 $ (25) $ 0 $ 0

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Outstanding Debt	Outstanding debt consisted of the following (in millions): October 31, 2024 January 31, 2024 2027 Notes $ 1,000 $ 1,000 2029 Notes 750 750 2032 Notes 1,250 1,250 Total principal amount 3,000 3,000 Less: unamortized debt discount and issuance costs (17) (20) Debt, noncurrent $ 2,983 $ 2,980
Schedule of Maturities of Long-term Debt	As of October 31, 2024, the future principal payments for the outstanding debt were as follows (in millions): Fiscal Period: Remainder of 2025 $ 0 2026 0 2027 0 2028 1,000 2029 0 Thereafter 2,000 Total principal amount $ 3,000
Schedule of Interest Expense	The following table sets forth the interest expense recognized related to our debt (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Contractual interest expense $ 28 $ 28 $ 83 $ 83 Interest cost related to amortization of debt discount and issuance costs 1 1 3 3 Total interest expense $ 29 $ 29 $ 86 $ 86

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Components of Lease Expense	The components of operating lease expense were as follows (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Operating lease cost $ 30 $ 27 $ 88 $ 82 Short-term lease cost 0 1 1 2 Variable lease cost 15 12 39 34 Total operating lease cost $ 45 $ 40 $ 128 $ 118
Information Related to Right-of-Use Assets and Lease Liabilities	Supplemental cash flow information related to our operating leases was as follows (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Cash paid for operating lease liabilities $ 29 $ 25 $ 80 $ 79 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities 22 30 123 94 Other information related to our operating leases was as follows: October 31, 2024 January 31, 2024 Weighted average remaining lease term (in years) 5 5 Weighted average discount rate 4.07 % 3.95 %
Maturities of Operating Lease Liabilities	As of October 31, 2024, maturities of operating lease liabilities were as follows (in millions): Fiscal Period: Remainder of 2025 $ 30 2026 108 2027 88 2028 77 2029 49 Thereafter 78 Total lease payments 430 Less imputed interest (50) Total operating lease liabilities $ 380

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Schedule of Repurchase Programs	The table below sets forth information regarding our share repurchase programs (in millions, except number of shares which are reflected in thousands, and per share data): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Total number of shares repurchased 649 677 2,538 1,312 Average price paid per share $ 242.42 $ 218.35 $ 236.73 $ 218.34 Amount repurchased $ 157 $ 147 $ 600 $ 286
Summary of Information Related to Restricted Stock Units Activity	RSU activity during the nine months ended October 31, 2024, was as follows (in thousands, except per share data): Number of Shares Weighted-Average Grant Date Fair Value Outstanding balance as of January 31, 2024 15,020 $ 203.94 RSUs granted 6,602 251.96 RSUs vested (3,495) 203.45 RSUs forfeited and canceled (1) (2,854) 206.65 Outstanding balance as of October 31, 2024 15,273 224.31 (1) Includes shares withheld in connection with the net share settlement of RSUs.

Contract Balances and Perform_2

Contract Balances and Performance Obligations (Tables)	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Contract Assets and Unearned Revenue	Contract assets and unearned revenue balances were as follows (in millions): Condensed Consolidated Balance Sheets Location October 31, 2024 January 31, 2024 Contract assets: Contract assets, current Trade and other receivables, net $ 414 $ 240 Contract assets, noncurrent Other assets 37 21 Total contract assets $ 451 $ 261 Unearned revenue (1) : Unearned revenue, current Unearned revenue $ 3,447 $ 4,057 Unearned revenue, noncurrent Unearned revenue, noncurrent 64 70 Total unearned revenue $ 3,511 $ 4,127 (1) Included in the unearned revenue balance are amounts related to professional services that are subject to cancellation and pro-rated refund rights of $69 million and $76 million as of October 31, 2024, and January 31, 2024, respectively.

Other Income (Expense), Net (Ta

Other Income (Expense), Net (Tables)	9 Months Ended
	Oct. 31, 2024
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other income (expense), net consisted of the following (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Interest income $ 86 $ 80 $ 267 $ 214 Interest expense (1) (29) (29) (86) (86) Other (2) 5 (10) (3) (14) Total other income (expense), net $ 62 $ 41 $ 178 $ 114 (1) Interest expense primarily includes the contractual interest expense of our debt obligations, and the related non-cash interest expense attributable to amortization of the debt discount and issuance costs. For further information, see Note 11, Debt . (2) Other primarily includes the net gains (losses) from our equity investments. For further information, see Note 3, Investments .

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share	The following table presents the calculation of basic and diluted net income (loss) per share (in millions, except number of shares, which are reflected in thousands, and per share data): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Class A Class B Class A Class B Class A Class B Class A Class B Net income (loss) per share, basic: Numerator: Net income (loss) $ 155 $ 38 $ 90 $ 24 $ 346 $ 86 $ 152 $ 41 Denominator: Weighted-average shares outstanding, basic 213,047 52,364 207,726 54,427 212,350 52,712 206,184 54,563 Net income (loss) per share, basic $ 0.73 $ 0.73 $ 0.43 $ 0.43 $ 1.63 $ 1.63 $ 0.74 $ 0.74 Net income (loss) per share, diluted: Numerator: Net income (loss) $ 155 $ 38 $ 90 $ 24 $ 346 $ 86 $ 152 $ 41 Reallocation of net income as a result of conversion of Class B to Class A common stock 38 0 24 0 86 0 41 0 Reallocation of net income to Class B common stock 0 0 0 (1) 0 (1) 0 (1) Net income (loss) for diluted calculation 193 38 114 23 432 85 193 40 Denominator: Weighted-average shares outstanding, basic 213,047 52,364 207,726 54,427 212,350 52,712 206,184 54,563 Conversion of Class B to Class A common stock 52,364 0 54,427 0 52,712 0 54,563 0 Dilutive effect of share-based awards 3,138 0 4,224 0 3,874 0 3,340 0 Weighted-average shares outstanding, diluted 268,549 52,364 266,377 54,427 268,936 52,712 264,087 54,563 Net income (loss) per share, diluted $ 0.72 $ 0.72 $ 0.43 $ 0.43 $ 1.61 $ 1.61 $ 0.73 $ 0.73
Shares Excluded from Diluted Net Income (Loss) Per Share	The effects of these potentially outstanding shares were not included in the calculation of diluted net income (loss) per share because the effect would have been anti-dilutive (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 Total weighted-average shares related to outstanding share-based awards 258 1,882 2,217 2,774

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Oct. 31, 2024
Segment Reporting [Abstract]
Summary of Revenues by Geographic Area	The following table sets forth revenues by geographic area (in millions): Three Months Ended October 31, Nine Months Ended October 31, 2024 2023 2024 2023 United States $ 1,623 $ 1,404 $ 4,676 $ 4,013 Other countries 537 462 1,559 1,324 Total revenues $ 2,160 $ 1,866 $ 6,235 $ 5,337
Long-lived Assets by Geographic Areas	Aggregate Property and equipment, net and Operating lease right-of-use assets by geographic area was as follows (in millions): October 31, 2024 January 31, 2024 United States $ 1,226 $ 1,199 Ireland 234 213 Other countries 138 111 Total long-lived assets $ 1,598 $ 1,523

Overview and Basis of Present_2

Overview and Basis of Presentation (Detail)	9 Months Ended
	Oct. 31, 2024 segment
Accounting Policies [Abstract]
Number of operating segments	1

Investments - Summary of Market

Investments - Summary of Marketable Securities (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 5,978	$ 6,553
Unrealized Gains	19	15
Unrealized Losses	(3)	(8)
Aggregate Fair Value	5,994	6,560
Included in Cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	148	759
Unrealized Gains	0	0
Unrealized Losses	0	0
Aggregate Fair Value	148	759
Included in Marketable securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	5,830	5,794
Unrealized Gains	19	15
Unrealized Losses	(3)	(8)
Aggregate Fair Value	5,846	5,801
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,660	2,072
Unrealized Gains	5	4
Unrealized Losses	(1)	(2)
Aggregate Fair Value	1,664	2,074
U.S. agency obligations
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	694	753
Unrealized Gains	2	2
Unrealized Losses	0	(1)
Aggregate Fair Value	696	754
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,058	2,496
Unrealized Gains	12	9
Unrealized Losses	(2)	(5)
Aggregate Fair Value	3,068	2,500
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	566	1,232
Unrealized Gains	0	0
Unrealized Losses	0	0
Aggregate Fair Value	$ 566	$ 1,232

Investments - Contractual Matur

Investments - Contractual Maturity of Debt Securities (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Due within 1 year	$ 2,983
Due in 1 year through 5 years	3,011
Total debt securities	$ 5,994	$ 6,560

Investments - Aggregate Fair Va

Investments - Aggregate Fair Value and Gross Unrealized Losses for Debt Securities In Unrealized Loss Position (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	$ 1,048	$ 2,081
Less than 12 Months, Unrealized Loss	(3)	(5)
12 Months or Greater, Fair Value	319	349
12 Months or Greater, Unrealized Loss	0	(3)
Fair Value	1,367	2,430
Unrealized Loss	(3)	(8)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	266	921
Less than 12 Months, Unrealized Loss	(1)	(2)
12 Months or Greater, Fair Value	120	78
12 Months or Greater, Unrealized Loss	0	(1)
Fair Value	386	999
Unrealized Loss	(1)	(3)
U.S. agency obligations
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	142	234
Less than 12 Months, Unrealized Loss	0	0
12 Months or Greater, Fair Value	15	100
12 Months or Greater, Unrealized Loss	0	(1)
Fair Value	157	334
Unrealized Loss	0	(1)
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value	640	921
Less than 12 Months, Unrealized Loss	(2)	(3)
12 Months or Greater, Fair Value	184	171
12 Months or Greater, Unrealized Loss	0	(1)
Fair Value	824	1,092
Unrealized Loss	$ (2)	(4)
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Less than 12 Months, Fair Value		5
Less than 12 Months, Unrealized Loss		0
12 Months or Greater, Fair Value		0
12 Months or Greater, Unrealized Loss		0
Fair Value		5
Unrealized Loss		$ 0

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Interest receivable	$ 48		$ 48		$ 35
Credit and non-credit losses on debt securities	0	$ 0	0	$ 0
Proceeds of sale of debt securities	48	24	115	42
Equity securities without readily determinable fair value, upward price adjustment, annual amount	5		6
Impairment loss on non-marketable equity securities	2	9		22
Loss upon exit and impairment loss			13
Equity securities, unrealized loss		4		2
Equity securities	$ 849	29	$ 849	29	$ 1,017
Proceeds from sale of available-for-sale securities, equity		$ 22		$ 52

Investments - Equity Investment

Investments - Equity Investments (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Equity securities	$ 849	$ 1,017	$ 29
Non-marketable equity investments measured using the measurement alternative	242	248
Equity investments	$ 1,091	$ 1,265

Investments - Equity Investme_2

Investments - Equity Investments Realized and Unrealized Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Net realized gains (losses) recognized on equity investments sold	$ 0	$ (1)	$ (3)	$ 2
Net unrealized gains (losses) recognized on equity investments held as of the end of the period	3	(13)	(4)	(24)
Total net gains (losses) recognized in Other income (expense), net	$ 3	$ (14)	$ (7)	$ (22)

Investments - Schedule of Non-M

Investments - Schedule of Non-Marketable Equity Investments (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Total initial cost	$ 210	$ 213
Cumulative net unrealized gains (losses)	32	35
Carrying value	$ 242	$ 248

Fair Value Measurements - Infor

Fair Value Measurements - Information about Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	$ 5,994	$ 6,560
Foreign currency derivative assets	46
Foreign currency derivative liabilities	25
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,664	2,074
U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	696	754
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	3,068	2,500
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	566	1,232
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivative assets	46	46
Total assets	6,889	7,623
Foreign currency derivative liabilities	25	27
Total liabilities	25	27
Fair Value, Measurements, Recurring | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,664	2,074
Fair Value, Measurements, Recurring | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	696	754
Fair Value, Measurements, Recurring | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	3,068	2,500
Fair Value, Measurements, Recurring | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	566	1,232
Fair Value, Measurements, Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	849	1,017
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivative assets	0	0
Total assets	2,513	3,091
Foreign currency derivative liabilities	0	0
Total liabilities	0	0
Fair Value, Measurements, Recurring | Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,664	2,074
Fair Value, Measurements, Recurring | Level 1 | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	849	1,017
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivative assets	46	46
Total assets	4,376	4,532
Foreign currency derivative liabilities	25	27
Total liabilities	25	27
Fair Value, Measurements, Recurring | Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 2 | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	696	754
Fair Value, Measurements, Recurring | Level 2 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	3,068	2,500
Fair Value, Measurements, Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	566	1,232
Fair Value, Measurements, Recurring | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency derivative assets	0	0
Total assets	0	0
Foreign currency derivative liabilities	0	0
Total liabilities	0	0
Fair Value, Measurements, Recurring | Level 3 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 0	$ 0

Deferred Costs (Details)

Deferred Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Deferred sales commission	$ 734		$ 734		$ 741
Amortization of deferred costs	64	$ 54	185	$ 155
Capitalized contract cost, impairment loss	$ 0	$ 0	$ 0	$ 0

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,573	$ 2,506
Less accumulated depreciation and amortization	(1,310)	(1,272)
Property and equipment, net	1,263	1,234
Computers, equipment, and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,402	1,387
Buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	740	726
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	245	213
Furniture, fixtures, and transportation equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	105	99
Land and land improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 81	$ 81

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 60	$ 52	$ 174	$ 149

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Millions	Oct. 08, 2024	Mar. 29, 2024	Oct. 31, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Goodwill			$ 3,479	$ 2,846
Evisort
Business Acquisition [Line Items]
Consideration paid for acquisition	$ 311
Goodwill	238
Evisort | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Acquisition-related intangible assets	$ 44
Weighted-Average Useful Lives (in Years)	6 years
Evisort | Customer relationships
Business Acquisition [Line Items]
Acquisition-related intangible assets	$ 28
Weighted-Average Useful Lives (in Years)	14 years
HiredScore
Business Acquisition [Line Items]
Consideration paid for acquisition		$ 530
Acquisition-related intangible assets		$ 135
Weighted-Average Useful Lives (in Years)		9 years
Goodwill		$ 410
HiredScore | Customer relationships
Business Acquisition [Line Items]
Acquisition-related intangible assets		$ 23
Weighted-Average Useful Lives (in Years)		14 years

Business Combinations - Summary

Business Combinations - Summary of Preliminary Purchase Consideration Allocation (Details) - USD ($) $ in Millions	Oct. 31, 2024	Mar. 29, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Goodwill	$ 3,479		$ 2,846
HiredScore
Business Acquisition [Line Items]
Cash		$ 11
Acquisition-related intangible assets		135
Goodwill		410
Other assets		12
Other liabilities		(38)
Total		$ 530

Business Combinations - Schedul

Business Combinations - Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details) - USD ($) $ in Millions	Oct. 08, 2024	Mar. 29, 2024
HiredScore
Business Acquisition [Line Items]
Acquisition-related intangible assets		$ 135
Weighted-Average Useful Lives (in Years)		9 years
HiredScore | Developed technology
Business Acquisition [Line Items]
Acquisition-related intangible assets		$ 111
Weighted-Average Useful Lives (in Years)		8 years
HiredScore | Customer relationships
Business Acquisition [Line Items]
Acquisition-related intangible assets		$ 23
Weighted-Average Useful Lives (in Years)		14 years
HiredScore | Trade name
Business Acquisition [Line Items]
Acquisition-related intangible assets		$ 1
Weighted-Average Useful Lives (in Years)		1 year
Evisort | Customer relationships
Business Acquisition [Line Items]
Acquisition-related intangible assets	$ 28
Weighted-Average Useful Lives (in Years)	14 years

Acquisition-Related Intangibl_3

Acquisition-Related Intangible Assets, Net - Schedule of Acquired Assets (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 864		$ 864		$ 657
Accumulated Amortization	(481)		(481)		(424)
Net Book Value	383		383		233
Amortization of intangible assets	20	$ 16	58	$ 58
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	473		473		318
Accumulated Amortization	(290)		(290)		(256)
Net Book Value	183		183		62
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	362		362		311
Accumulated Amortization	(163)		(163)		(140)
Net Book Value	199		199		171
Backlog
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	15		15		15
Accumulated Amortization	(15)		(15)		(15)
Net Book Value	0		0		0
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	14		14		13
Accumulated Amortization	(13)		(13)		(13)
Net Book Value	$ 1		$ 1		$ 0

Acquisition-Related Intangibl_4

Acquisition-Related Intangible Assets, Net - Schedule of Future Amortization Expense (Detail) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2025	$ 21
2026	82
2027	57
2028	53
2029	43
Thereafter	127
Net Book Value	$ 383	$ 233

Other Assets - Schedule of Othe

Other Assets - Schedule of Other Assets (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Other Assets [Line Items]
Non-marketable equity and other investments	$ 245	$ 248
Contract assets	37	21
Technology patents and other intangible assets, net	383	233
Prepayments for goods and services	16	14
Derivative assets	13	14
Deposits	10	8
Other	18	6
Total other assets	365	337
Patented Technology and Other Intangible Assets, Net
Other Assets [Line Items]
Technology patents and other intangible assets, net	$ 26	$ 26

Other Assets - Summary of Futur

Other Assets - Summary of Future Estimated Amortization Expense Related to Acquired Land Leasehold Interest and Technology Patents (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Remainder of 2025	$ 21
2026	82
2027	57
2028	53
2029	43
Thereafter	127
Net Book Value	383	$ 233
Patented Technology and Other Intangible Assets, Net
Finite-Lived Intangible Assets [Line Items]
Remainder of 2025	1
2026	4
2027	3
2028	3
2029	3
Thereafter	12
Net Book Value	$ 26	$ 26

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Derivative [Line Items]
Net gains on cash flow hedges estimated to be reclassified into income within the next 12 months	$ 18
Non-designated hedges | Long
Derivative [Line Items]
Derivative, notional amount	120	$ 237
Non-designated hedges | Short
Derivative [Line Items]
Derivative, notional amount	54	11
Cash flow hedges | Cash flow hedges | Long
Derivative [Line Items]
Derivative, notional amount	2,800	2,500
Cash flow hedges | Cash flow hedges | Short
Derivative [Line Items]
Derivative, notional amount	$ 412	$ 399
Cash flow hedges | Cash flow hedges | Maximum
Derivative [Line Items]
Derivative, remaining maturity (in months)	60 months

Derivative Instruments - Fair V

Derivative Instruments - Fair Values of Outstanding Derivative Instruments (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Derivatives, Fair Value [Line Items]
Derivative assets:	$ 46	$ 46
Derivative liabilities:	25	27
Non-designated hedges | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets:	3	2
Non-designated hedges | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	1	1
Cash flow hedges | Cash flow hedges | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets:	30	30
Cash flow hedges | Cash flow hedges | Other assets
Derivatives, Fair Value [Line Items]
Derivative assets:	13	14
Cash flow hedges | Cash flow hedges | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	12	14
Cash flow hedges | Cash flow hedges | Other liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	$ 12	$ 12

Derivative Instruments - Effect

Derivative Instruments - Effect of Cash Flow Hedges on Income Statement (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Revenues	$ 2,160	$ 1,866	$ 6,235	$ 5,337
Costs and expenses	1,995	1,778	5,895	5,233
Revenues
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) related to cash flow hedges	7	16	23	49
Costs and expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) related to cash flow hedges	$ 3	$ 1	$ (2)	$ 2

Derivative Instruments - Pre-ta

Derivative Instruments - Pre-tax Gains (Losses) Associated with Cash Flow Hedges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in OCI	$ 0	$ 67	$ 11	$ 54
Revenues	2,160	1,866	6,235	5,337
Costs and expenses	1,995	1,778	5,895	5,233
Derivative assets:	46		46		$ 46
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	46		46
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(25)		(25)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	21		21
Counterparty A
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets:	13		13
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	13		13
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(4)		(4)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	9		9
Counterparty B
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets:	9		9
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	9		9
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(6)		(6)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	3		3
Counterparty C
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets:	3		3
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	3		3
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(1)		(1)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	2		2
Counterparty D
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets:	17		17
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	17		17
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(13)		(13)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	4		4
Counterparty E
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets:	1		1
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	1		1
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	0		0
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	1		1
Counterparty F
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets:	2		2
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0		0
Foreign currency derivative assets	2		2
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(1)		(1)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0		0
Derivative Asset, Fair Value, Amount Offset Against Collateral	1		1
Revenues
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) reclassified from AOCI into income (effective portion)	7	16	23	49
Costs and expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) reclassified from AOCI into income (effective portion)	3	1	(2)	2
Other income (expense), net
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) related to non-designated hedges	$ 0	$ 6	$ (2)	$ 8

Derivative Instruments - Offset

Derivative Instruments - Offsetting Assets (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	$ 46	$ 46
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	46
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(25)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	21
Counterparty A
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	13
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	13
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(4)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	9
Counterparty B
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	9
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	9
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(6)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	3
Counterparty C
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	3
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	3
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(1)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	2
Counterparty D
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	17
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	17
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(13)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	4
Counterparty E
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	1
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	1
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	0
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	1
Counterparty F
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	2
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	2
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(1)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	1
Counterparty G
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	1
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	1
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	0
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	$ 1

Derivative Instruments - Offs_2

Derivative Instruments - Offsetting Liabilities (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	$ 25	$ 27
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	25
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(25)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty A
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	4
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	4
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(4)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty B
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	6
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	6
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(6)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty C
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	1
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	1
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(1)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty D
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	13
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	13
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(13)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty F
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	1
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	1
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(1)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	$ 0

Debt - Outstanding Debt (Detail

Debt - Outstanding Debt (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Debt Instrument [Line Items]
Total principal amount	$ 3,000	$ 3,000
Less: unamortized debt discount and issuance costs	(17)	(20)
Debt, noncurrent	2,983	2,980
2027 Notes
Debt Instrument [Line Items]
Total principal amount	1,000	1,000
2029 Notes
Debt Instrument [Line Items]
Total principal amount	750	750
2032 Notes
Debt Instrument [Line Items]
Total principal amount	$ 1,250	$ 1,250

Debt - Schedule of Maturities o

Debt - Schedule of Maturities of Long-term Debt (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Debt Instrument [Line Items]
Total principal amount	$ 3,000	$ 3,000
Senior Notes
Debt Instrument [Line Items]
Remainder of 2025	0
2026	0
2027	0
2028	1,000
2029	0
Thereafter	2,000
Total principal amount	$ 3,000

Debt - Senior Notes and Credit

Debt - Senior Notes and Credit Agreement (Details) - USD ($)	9 Months Ended
	Oct. 31, 2024	Jan. 31, 2024	Apr. 30, 2022
Debt Instrument [Line Items]
Debt discount and issuance costs	$ 17,000,000	$ 20,000,000
Senior Notes
Debt Instrument [Line Items]
Principal			$ 3,000,000,000
Debt discount and issuance costs			27,000,000
Fair value of Senior Notes	$ 2,800,000,000	$ 2,800,000,000
2027 Notes | Senior Notes
Debt Instrument [Line Items]
Principal			$ 1,000,000,000
Contractual interest rate			3.50%
Effective interest rate	3.67%
2029 Notes | Senior Notes
Debt Instrument [Line Items]
Principal			$ 750,000,000
Contractual interest rate			3.70%
Effective interest rate	3.82%
2032 Notes | Senior Notes
Debt Instrument [Line Items]
Principal			$ 1,250,000,000
Contractual interest rate			3.80%
Effective interest rate	3.90%
2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 1,000,000,000
Long-term line of credit	$ 0
Debt instrument, maximum leverage ratio	3.50
Debt instrument, maximum leverage ratio step up	4.50
Base Rate | Minimum | 2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	0%
Base Rate | Maximum | 2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Secured Overnight Financing Rate (SOFR) | 2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	0.10%
Secured Overnight Financing Rate (SOFR) | Minimum | 2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	0.75%
Secured Overnight Financing Rate (SOFR) | Maximum | 2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%

Debt - Schedule of Interest Exp

Debt - Schedule of Interest Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Debt Disclosure [Abstract]
Contractual interest expense	$ 28	$ 28	$ 83	$ 83
Interest cost related to amortization of debt discount and issuance costs	1	1	3	3
Total interest expense	$ 29	$ 29	$ 86	$ 86

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	$ 335	$ 289
Operating lease liabilities	380	$ 316
Operating lease, lease not yet commenced, payment	$ 90
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, lease not yet commenced, term (years)	5 years
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, lease not yet commenced, term (years)	10 years

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Leases [Abstract]
Operating lease cost	$ 30	$ 27	$ 88	$ 82
Short-term lease cost	0	1	1	2
Variable lease cost	15	12	39	34
Total operating lease cost	$ 45	$ 40	$ 128	$ 118

Leases - Information Related to

Leases - Information Related to Our Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024
Leases [Abstract]
Cash paid for operating lease liabilities	$ 29	$ 25	$ 80	$ 79
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities	$ 22	$ 30	$ 123	$ 94
Weighted average remaining lease term (in years)	5 years		5 years		5 years
Weighted average discount rate	4.07%		4.07%		3.95%

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remainder of 2025	$ 30
2026	108
2027	88
2028	77
2029	49
Thereafter	78
Total lease payments	430
Less imputed interest	(50)
Total operating lease liabilities	$ 380	$ 316

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Millions	1 Months Ended		9 Months Ended
	Dec. 31, 2022 $ / shares shares	Jun. 30, 2022 shares	Oct. 31, 2024 USD ($) vote $ / shares shares	Aug. 28, 2024 USD ($)	Feb. 29, 2024 USD ($)	Nov. 30, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (in shares) | shares			100
Exercisable (in shares) | shares			100
Options outstanding, weighted-average exercise price (in dollars per share) | $ / shares			$ 29.43
Exercisable, weighted-average exercise price (in dollars per share) | $ / shares			$ 29.43
Options outstanding, aggregate intrinsic value | $			$ 16
Exercisable, aggregate intrinsic value | $			16
Unrecognized compensation cost | $			$ 0
February 2024 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amount repurchased | $					$ 500
2022 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares) | shares		30,000
Common stock available for future grants (in shares) | shares			17,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock available for future grants (in shares) | shares			3,000
November 2022 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amount repurchased | $						$ 500
August 2024 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amount repurchased | $				$ 1,000
Authorized remaining amount to be purchased | $			$ 902
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of fair market value of stock at which employees are granted shares		85%
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of vesting (in years)			4 years
Unrecognized compensation cost, other than options | $			$ 2,600
Unrecognized compensation cost recognized over weighted-average period (in years)			3 years
RSUs granted (in shares) | shares			6,602
Weighted average grant date fair value (in dollars per share) | $ / shares			$ 251.96
Market-Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, other than options | $			$ 11
Unrecognized compensation cost recognized over weighted-average period (in years)			3 years
Expected volatility	40%
Risk-free interest rate	4%
Expected term (in years)	6 years
Weighted average grant date fair value (in dollars per share) | $ / shares	$ 124.80
Requisite service period (in years)	5 years
Market-Based Restricted Stock Units | Co-CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted (in shares) | shares	300
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of vesting (in years)			5 years
Period of which options become exercisable (in years)			10 years
Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, outstanding (in shares) | shares			213,000
Common stock, votes per share | vote			1
Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, outstanding (in shares) | shares			52,000
Common stock, votes per share | vote			10

Stockholders' Equity - Share Re

Stockholders' Equity - Share Repurchase Program (Details) - Common stock: - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Share Repurchase Program [Line Items]
Total number of shares repurchased (in shares)	649	677	2,538	1,312
Average price paid per share (in dollars per share)	$ 242.42	$ 218.35	$ 236.73	$ 218.34
Amount repurchased	$ 157	$ 147	$ 600	$ 286

Stockholders' Equity - Restrict

Stockholders' Equity - Restricted Stock Units Activity (Details) - Restricted Stock Units shares in Thousands	9 Months Ended
	Oct. 31, 2024 $ / shares shares
Number of Shares
Outstanding balance, beginning (in shares) | shares	15,020
RSUs granted (in shares) | shares	6,602
RSUs vested (in shares) | shares	(3,495)
RSUs forfeited and canceled (in shares) | shares	(2,854)
Outstanding balance, ending (in shares) | shares	15,273
Weighted-Average Grant Date Fair Value
Outstanding balance, beginning (in dollars per share) | $ / shares	$ 203.94
RSUs granted (in dollars per share) | $ / shares	251.96
RSUs vested (in dollars per share) | $ / shares	203.45
RSUs forfeited and canceled (in dollars per share) | $ / shares	206.65
Outstanding balance, ending (in dollars per share) | $ / shares	$ 224.31

Contract Balances and Perform_3

Contract Balances and Performance Obligations - Contract Assets and Unearned Revenue (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Contract assets:
Contract assets, current	$ 414	$ 240
Contract assets, noncurrent	37	21
Total contract assets	451	261
Unearned revenue
Unearned revenue, current	3,447	4,057
Unearned revenue, noncurrent	64	70
Total unearned revenue	3,511	4,127
Professional Services, Subject To Cancellation And Pro-Rated Refund Rights
Unearned revenue
Total unearned revenue	$ 69	$ 76

Contract Balances and Perform_4

Contract Balances and Performance Obligations - Narrative (Details) - USD ($) $ in Billions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Subscription revenue recognized that was included in total unearned revenue balance at beginning of period	$ 1.6	$ 1.4	$ 3.6	$ 3.1
Subscription services
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue is expected to be recognized from remaining performance obligations for subscription contracts	22.2		22.2
Subscription services | Minimum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue is expected to be recognized from remaining performance obligations for subscription contracts	$ 7		$ 7
Recognition period (in months)	12 months		12 months
Subscription services | Maximum | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue is expected to be recognized from remaining performance obligations for subscription contracts	$ 12.3		$ 12.3
Recognition period (in months)	24 months		24 months

Other Income (Expense), Net (De

Other Income (Expense), Net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Other Income and Expenses [Abstract]
Interest income	$ 86	$ 80	$ 267	$ 214
Interest expense	(29)	(29)	(86)	(86)
Other	5	(10)	(3)	(14)
Other income (expense), net	$ 62	$ 41	$ 178	$ 114

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income tax provision	$ 34	$ 15	$ 86	$ 25

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Numerator:
Net income (loss)	$ 193	$ 114	$ 432	$ 193
Denominator:
Weighted-average shares outstanding, basic (in shares)	265,411	262,153	265,062	260,747
Weighted-average shares outstanding, diluted (in shares)	268,549	266,377	268,936	264,087
Net income (loss) per share, basic (in dollars per share)	$ 0.73	$ 0.43	$ 1.63	$ 0.74
Net income (loss) per share, diluted (in dollars per share)	$ 0.72	$ 0.43	$ 1.61	$ 0.73
Class A
Numerator:
Net income (loss)	$ 155	$ 90	$ 346	$ 152
Reallocation of net income as a result of conversion of Class B to Class A common stock	38	24	86	41
Reallocation of net income to Class B common stock	0	0	0	0
Net income (loss) for diluted calculation	$ 193	$ 114	$ 432	$ 193
Denominator:
Weighted-average shares outstanding, basic (in shares)	213,047	207,726	212,350	206,184
Conversion of Class B to Class A common stock (in shares)	52,364	54,427	52,712	54,563
Dilutive effect of share-based awards (in shares)	3,138	4,224	3,874	3,340
Weighted-average shares outstanding, diluted (in shares)	268,549	266,377	268,936	264,087
Net income (loss) per share, basic (in dollars per share)	$ 0.73	$ 0.43	$ 1.63	$ 0.74
Net income (loss) per share, diluted (in dollars per share)	$ 0.72	$ 0.43	$ 1.61	$ 0.73
Class B
Numerator:
Net income (loss)	$ 38	$ 24	$ 86	$ 41
Reallocation of net income as a result of conversion of Class B to Class A common stock	0	0	0	0
Reallocation of net income to Class B common stock	0	(1)	(1)	(1)
Net income (loss) for diluted calculation	$ 38	$ 23	$ 85	$ 40
Denominator:
Weighted-average shares outstanding, basic (in shares)	52,364	54,427	52,712	54,563
Conversion of Class B to Class A common stock (in shares)	0	0	0	0
Dilutive effect of share-based awards (in shares)	0	0	0	0
Weighted-average shares outstanding, diluted (in shares)	52,364	54,427	52,712	54,563
Net income (loss) per share, basic (in dollars per share)	$ 0.73	$ 0.43	$ 1.63	$ 0.74
Net income (loss) per share, diluted (in dollars per share)	$ 0.72	$ 0.43	$ 1.61	$ 0.73

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Summary of Diluted Net Income (Loss) Per Common Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Total weighted-average shares related to outstanding share-based awards
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Total anti-dilutive securities (in shares)	258	1,882	2,217	2,774

Geographic Information - Summar

Geographic Information - Summary of Revenues by Geographic Area (Details) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024 USD ($) market	Oct. 31, 2023 USD ($)	Oct. 31, 2024 USD ($) market	Oct. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Number of primary geographical markets | market	2		2
Revenues	$ 2,160	$ 1,866	$ 6,235	$ 5,337
United States
Disaggregation of Revenue [Line Items]
Revenues	1,623	1,404	4,676	4,013
Other countries
Disaggregation of Revenue [Line Items]
Revenues	$ 537	$ 462	$ 1,559	$ 1,324

Geographic Information - Long-L

Geographic Information - Long-Lived Assets (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Long-Lived Assets [Line Items]
Total long-lived assets	$ 1,598	$ 1,523
United States
Long-Lived Assets [Line Items]
Total long-lived assets	1,226	1,199
Ireland
Long-Lived Assets [Line Items]
Total long-lived assets	234	213
Other countries
Long-Lived Assets [Line Items]
Total long-lived assets	$ 138	$ 111